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Abstract
The European Commission is routinely asking EFSA for scientiﬁc and technical support in the
epidemiological analysis of animal disease outbreaks (i.e. African swine fever, lumpy skin disease and
avian inﬂuenza) and to report or assess surveillance data (i.e. Echinococcus multilocularis and avian
inﬂuenza). For this purpose, EFSA has over the last years carried out several data collections and
gathered speciﬁc information on outbreaks, surveillance activities and concerned animal populations (i.e.
poultry, domestic pigs, cattle and wildlife such as wild boar). EFSA aims to work together closely with
Member States in order to (i) reduce the Member States’ manual input of the data to be submitted to
EFSA; (ii) avoid double reporting to EFSA; (iii) provide the Member States with tools to produce
automatically their own draft national reports on animal health and surveillance in a protected
environment to ensure data protection; (iv) increase the quality of the data received from the Member
States; and (v) shorten the time to retrieve up-to-date data, relevant for risk assessment purposes. With
this purpose, EFSA launched a project called SIGMA. It is important to highlight that the SIGMA – Animal
Disease Data Model (r-ADM) focuses on data which are known to be already collected by several
Member States under different legal frameworks and for different purposes. The version presented in
this report, will be subject to modiﬁcations and updates derived from the feedback during the
implementation phase.
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1. Background
The European Commission is routinely asking the European Food Safety Authority (EFSA) for
scientiﬁc and technical support in the epidemiological analysis of animal disease outbreaks (i.e. African
swine fever (ASF), lumpy skin disease (LSD) and avian inﬂuenza (AI)) and to report or assess
surveillance data (i.e. Echinococcus multilocularis (EM) and AI). For this purpose, EFSA has over the
last years carried out several data collections and gathered speciﬁc information on outbreaks,
surveillance activities and concerned animal populations (i.e. poultry, domestic pigs, cattle and wildlife
such as wild boar). These mandated undertakings related to speciﬁc animal diseases can be
considered ‘ad hoc animal health data collections’. Data collections on animal populations are also
implemented in relation to the EFSA–ECDC zoonoses summary report (EFSA and ECDC, 2017) and by
EUROSTAT, but the resolution of the data is often not sufﬁciently detailed to be used in analytical
epidemiology and risk assessments. In addition, EFSA is currently using ad hoc data models speciﬁcally
tailored to a single disease, with a consequent lack of harmonisation across the different data
collection processes and with the zoonoses data model (EFSA, 2017).
Taking into account the experience gained by EFSA in the ﬁeld of the animal disease data collection over
the last decade and considering: (i) the increasing demand of data-driven scientiﬁc advice to the risk
managers to face animal health threatens and, on the other hand, (ii) the steady progress made by
information technology, EFSA decided to initiate a process of harmonisation across the different animal
health data collection activities, including zoonotic agents, linked to outbreaks and monitoring/surveillance.
EFSA aims to work together closely with Member States on the technical aspects of ‘ad hoc animal
health data collections’, in particular to:
• reduce the Member States’ manual input of the data to be submitted to EFSA;
• avoid double reporting to EFSA;
• provide the Member States with tools to produce automatically their own draft national reports
on animal health and surveillance in a protected environment to ensure data protection;
• increase the quality of the data received from the Member States;
• shorten the time to retrieve up-to-date data, relevant for risk assessment purposes.
With this purpose, EFSA launched a project called SIGMA. This report provides a brief outline of the
entire project and describes the details on a unique and harmonised Animal Disease Data Model
(r-ADM) and the possible steps leading to its adoption.
It is important to highlight that the r-ADM focuses on data which are known to be already
collected by several Member States under different legal frameworks and for different purposes. The
version presented in this report, will be subject to modiﬁcations and updates derived from the
feedback during the implementation phase.
2. The SIGMA project in a nutshell
The SIGMA project originates from an internal critical assessment of the current practices to collect
data on animal population and animal diseases and has the purpose of optimising the entire process.
As a preliminary step, EFSA performed an internal technical analysis to identify all limitations related to
the ongoing data collections. The main problems were: (i) each mandate (i.e. a formal request for
support to EFSA by the European Commission) usually entails the design of an ad hoc data model making
it unique and only partially compatible with those designed for other mandates; (ii) the ad hoc data
models are designed to collect information about ongoing outbreaks, resulting in Member States (MSs)
assigning extra resources to ﬁll in these data models, at a time when they should be focusing on disease
control focus on disease control; (iii) despite the considerable effort put in the past years to harmonise
the deﬁnitions across the European Union (EU) MSs, there are still unavoidable differences due to many
different factors, which make the data analysis a complicated task and require heavy assumptions.
Nowadays, information technology (IT) offers solutions that were not available a few years ago. In
addition, the majority of the data (related to outbreaks, surveillance activities, laboratory analysis and
animal populations) that EFSA needs to produce sound scientiﬁc outputs are in most cases already
stored at country level and shared with EFSA upon request. Therefore, it is a matter of gathering/
collating, with suitable agreement, the existing data (properly anonymised), standardise them and
safely store them in the EFSA Scientiﬁc Data Warehouse (hereinafter also referred as S-DWH)1 using
the tools made available by the current technology.
1 https://www.efsa.europa.eu/en/science/data
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For illustrative purposes, Figure 1 shows the optimal and ﬁnal setting of the process of data
collection/collation and reporting and how MSs could contribute to and beneﬁt from the SIGMA
project. Note that SIGMA will deal with data already submitted to EFSA but using different channels
and aggregated in many different ways according to the topic and the purpose.
The outbreak/disease notiﬁcation data will still have to be submitted manually into the Animal
Disease Notiﬁcation System (ADNS), as currently done, following the relevant legislation in force.
However, the aim is to connect the ADNS and the S-DWH, so that the MSs will be requested to provide
EFSA solely with the additional epidemiological information. These additional epidemiological data will
be collected by means of the EFSA Data Collection Framework (hereinafter, DCF) and its integrated
controlled terminology and validation rules. As these epidemiological data are essential to estimate
important parameters (e.g. prevalence, occurrence of disease) and to correctly interpret information
originating from risk-based sampling designs (e.g. sampling strategy, geographical allocation of the
samples, etc.), the SIGMA project, with the help of the awarded consortium, aims at centralising the
data ﬂow towards a unique Country Data Collection Point (CDCP, as an ideal set up and in agreement
with the MS). Once all the relevant information is in the CDCP, they can be standardised against the
r-ADM by means of dedicated ‘Extract-Transform-Load’ (ETL) processes (i.e. the data will be
automatically converted from the national data model into the r-ADM). At the end of the standardisation
process, the information will be ready for provisioning to EFSA. The data upload should be automatically
handled by the system taking advantage of the data exchange protocol implemented in DCF in
compliance to EFSA Guidance on Data Exchange v2.0. The MS can choose to send data to EFSA
automatically (e.g. a periodical submission on a monthly basis) or to send them on an ‘ad hoc basis’. EFSA
will therefore receive a set of pre-standardised data from the MSs and will be able to (i) perform risk
assessment at European level using harmonised information and producing highly comparable outputs;
and (ii) give the MSs the opportunity of using web applications to analyse their own data and produce any
type of report, including the ones foreseen by law. Even in this case, this will not be an obligation: each
MS will be able to choose between the EFSA tools and any other way to analyse their data.
Yellow spots: National Data Sources; CDCP: Country Data Collection Point; ADNS: Animal Disease Notiﬁcation
System; Keyboard icon: manual input; Robot icon: automated process; Web Tools: web applications designed
to produce standard reports, including the ones required by the European Commission to the Member States
(MSs); Purple arrow ‘Alternative’: transmission of the reports that the European Commission requires from the
MSs without using the tools made available by EFSA.
Figure 1: Data ﬂow from the different data providers (public institutions and MSs) to the EFSA
Scientiﬁc Data Warehouse
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Considering the complexity of the project and the ambition of creating a framework that could be
used by all MSs, EFSA launched a call asking for support in the technical implementation of the
project. The awarded consortium is led by the Istituto Zooproﬁlattico Sperimentale (IZS) Abruzzo e
Molise ‘G. Caporale’ and is in partnership with the Friedrich Loefﬂer Institut (FLI), the Swedish National
Veterinary Institute (SVA), the Bulgarian Food Safety Agency (BFSA) and the Institute of Veterinary
Medicine and Animal Sciences, Estonian University of Life Sciences.
The SIGMA consortium will provide technical support to interested MSs:
• to improve animal health data ﬂows within the country (ideally, from the national data sources
to the CDCP);
• to improve animal health data ﬂow from the CDCP to EFSA;
• to standardise the MS data based on the r-ADM;
• to connect (preferably existing) tools for data analysis to the S-DWH to facilitate harmonised
reporting by national and European risk assessment bodies.
It is important to specify that there are no legal obligations behind the project and the decision of
taking advantage of this framework is entirely on the single country.
SIGMA has been planned as a three-year project with three main phases as described in the
following sections.
2.1. SIGMA Phase 1
In this ﬁrst phase, the main goals are:
• to design a harmonised data model, the SIGMA Animal Disease Data Model (r-ADM) able
to gather, from the concerned MSs and from the existing data collection systems, those data
essential to address the requests related to the ongoing mandates (ASF, AI, LSD, EM);
• to produce a ‘country card’, i.e. a comprehensive overview, at MS level, of the authorities
responsible for the collection of the data related to animal health and animal population (at
this point in time, considering the ongoing mandates received from the European Commission,
poultry, bovines and pigs);
• to outline the data ﬂows in place, within each MS and from each MS to EFSA, to highlight
potential drawbacks and propose technical solutions to optimise the system;
• to provide a list of online tools for the data analysis and for the reporting of disease
outbreaks/surveillance activities with the aim to make them available to the MSs to query the
S-DWH, where provided data are stored. Particular attention will be given to those
consolidated tools that are already in use:
 the Classical Swine Fever/African Swine Fever (CSF/ASF) wild boar surveillance database2 EuFMD-iS model.3,4
2.2. SIGMA Phase 2
The second phase will be mainly dedicated to the concrete implementation of the framework
with the MSs that volunteer to take part in the pilot. This phase will be targeted on those diseases that
EFSA has been requested to deal with (AI, ASF and LSD). In detail:
• Planning and development of solutions to enhance the data ﬂows;
• Data mapping (matching between MS naming conventions and r-ADM);
• Support the volunteering MSs in designing the ETL processes to select, transform and
transmit the standardised relevant national data to the EFSA DWH.
These activities will be performed on outbreak and surveillance data on AI, ASF and LSD and
related animal populations, based on the speciﬁc situation of the volunteering MSs.
2.3. SIGMA Phase 3
In the third phase, based on the outcomes from the previous phases, the implementation of the
SIGMA approach will be (i) ﬁnalised; and (ii) extended to other MSs and/or other diseases (in case
2 http://public.surv-wildboar.eu/Default.aspx
3 http://www.fao.org/ag/againfo/programmes/en/empres/news_160318b.html
4 https://www.youtube.com/watch?v=PeTTs2lOPk4&feature=youtu.be
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of new mandates from the European Commission) and/or other animal population data that were not
included in Phase 2. In addition, the selected web tools will be connected to the DWH and made freely
available to the MSs providing the data.
In detail:
• ETL processes: implementation of the ETL processes in the volunteering MSs;
• Analytical interactive online tools: connection of relevant online tools to EFSA’s DWH to
support AI, ASF, LSD disease outbreak analysis and reporting;
• Analytical interactive online tools: connection of relevant online tools to EFSA’s DWH to
support Avian Inﬂuenza Surveillance and Echinococcus multilocularis surveillance analysis and
reporting.
3. The SIGMA Animal Disease Data Model (r-ADM)
The ﬁrst milestone of Phase 1 of the SIGMA project is about the creation of a comprehensive data
model that is able to encompass different needs related to animal disease risk assessment. The steps
followed to achieve the r-ADM are described in the following points (Figure 2).
1) The ﬁrst step towards the harmonisation of the data collection was to analyse and
summarise the risk assessment requests from the risk managers, i.e. European
Commission (see Section 5.1, Appendices D and E);
2) Once the risk assessment questions were retrieved, they were grouped into categories,
each characterised by a common possible statistical approach. The outcome of this step was
a set of Envisaged analysis (i.e. a set of hypothetical statistical approaches that could
address the identiﬁed risk assessment requests), essential to identify the data needs (see
point 3 and Section 5.2);
3) As each statistical approach needs speciﬁc input data, the Preliminary Plan of Analysis
played a crucial role to identify and deﬁne exactly and in a concrete way the type of data
needed (see Section 5.3);
4) The data need was then formalised in a data model: the SIGMA Animal Disease Data
Model (r -ADM, see Section 5.4);
5) The r -ADM was then tested against all the ongoing EFSA data collection to make
sure that the experience gained over the last years was well integrated and the r-ADM was
comprehensive enough to encompass all types of risk assessment needs (see Section 7).
The ﬁrst version of the model was then circulated among the members of the Animal Health
Network (see also the EFSA event report ‘SIGMA A comprehensive animal disease data collection
approach’5) and of the Animal Health and Welfare Panel to check its compatibility with all possible
scenarios. See Section 4 for more information about the features of the r-ADM.
The ﬁnal goal was to have in the EFSA DWH a set of European data fully harmonised and
ready to be used:
• by EFSA to run the statistical analysis envisaged in the Preliminary Plan of Analysis and
address the requests from the Risk Managers
• by the MSs to create their draft country reports to be submitted to the relevant institutions as
laid down in the relevant legislation in force (e.g. Commission Regulation (EU) No 1152/2011
on Echinococcus multilocularis)
The objective of this scientiﬁc report is to describe the ﬁve steps of the SIGMA harmonisation
process, up to the development of the SIGMA Animal Data Model on animal diseases (r-ADM).
5 http://www.efsa.europa.eu/en/supporting/pub/en-1428
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It is important to note that the data model resulting from this exercise will be tailored to ﬁt the animal
diseases for which EFSA has an ongoing mandate, i.e. ASF, LSD, AI, EM, and will be compatible with the
data model used for zoonotic diseases included in the EFSA annual report (EFSA and ECDC, 2017). Diseases,
other than those for which EFSA has an ongoing mandate, will only be included in the r-ADM if EFSA would
receive a speciﬁc mandate to provide the risk managers with scientiﬁc information on those diseases.
The development of this scientiﬁc report is linked to the strategic objectives to widen EFSA’s
evidence base and optimise access to its data, build the EU’s scientiﬁc assessment capacity and
knowledge community and prepare for future risk assessment challenges (EFSA Strategy, 2020,
https://www.efsa.europa.eu/sites/default/files/151008.pdf).
4. The r-Animal Disease Data Model
The r-ADM will be a compromise between the justiﬁable ambition of addressing the risk
assessment questions using the most sophisticated methodology and the pragmatism on the actual
data availability across the different data providers (MSs, International Databases), while ensuring
there are no additional resource requirements for the MS. The r-ADM was designed to be harmonised,
compatible, ﬂexible and ﬁt for purpose (see Figure 4).
With the publication of this scientiﬁc report, the r-ADM can be considered consolidated in its ﬁrst
release (r-ADM v.1). From now onwards EFSA, within the framework of the SIGMA project and with
the help of the awarded Consortium, will work together with the MSs to improve and automate, where
possible, the data ﬂow from the national databases to the EFSA DWH.
It is important to highlight that, for the MSs that will volunteer to be part of the project, the
development of the necessary technical steps will be performed by the SIGMA Consortium
and ﬁnanced by EFSA.
4.1. Harmonised
The ﬁrst level of harmonisation was conducted internally, at EFSA (internal harmonisation).
Starting from the different ongoing ad hoc data collections, EFSA harmonised the way the data were
collected using a unique way of classiﬁcation, based on existing standards where possible, e.g. SSD2
(ANSVSA, 2015) or setting new standards when these did not already exist (see Figure 4).
The second level of harmonisation was conducted across the different data providers in the
different Member States (external harmonisation). It should be pointed out that in this case, what
SIGMA is proposing is a harmonisation sensu stricto rather than a difﬁcult ‘alignment’. It is well known
that each country has its way of naming and classifying at least part of the information generated in
the ﬁeld for many reasons, including history and culture (Figure 3). Each country will have a speciﬁc
name for ‘pear’. An ‘alignment’ would entail a new name for this fruit to be imposed for the purpose of
collecting comparable data. On the contrary, a real harmonisation builds on the existing concepts: it is
sufﬁcient to know how that speciﬁc fruit is called in the different countries and translate it into any
meaningful way, according to the purpose. It is also clear that, assuming a reasonable stability over
time of the naming convention within each country, this translation can be completely automated.
Therefore, the MSs will not have to modify anything of the way they collect the data. Nonetheless,
EFSA will have a set of standardised and therefore highly comparable data available for the analysis.
Figure 2: Sources of information in the process generating the SIGMA-Animal Disease Data Model (r-ADM)
SIGMA Animal Disease Data Model: a comprehensive approach
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4.2. Flexible
The r-ADM is ﬂexible enough to adapt to the different settings in place and/or solutions adopted
by the different Member States. It is also able to gather data related to different types of activity in
the ﬁeld, e.g. surveillance, monitoring or outbreak related sampling (see Figure 4).
Particular attention was dedicated to the level of resolution (or scale) of the data. An example is
given by the geographical location of the unit of interest, e.g. a farm. The r-ADM has been designed
to deal with the highest resolution possible, i.e. the geographic coordinates (x–y, latitude–longitude) of
an establishment (e.g. a farm, see Table 1). However, a MS can decide not to share the data with
ESFA at this level of resolution. In this case, the r-ADM offers the option to report the location of the
establishment at lower level of geographical resolution (e.g. the NUTS3 regions). From a more
technical point of view, in order to fulﬁl the requirements of the S-DWH, when a data provider wants
to provide data at a lower resolution, the data will be collected in an ‘aggregate-able’ structure, as
shown in Table 2). In this way, it will be possible at least to know the number of farms in each NUTS3
region.
Figure 3: Harmonisation sensu stricto, i.e. building on the existing. There is no need to impose new
naming conventions to the data providers. Once it is known how a given object is called (in
this case and just for illustrative purposes, a pear) it is possible to translate the information
into a standard language
Table 1: Fictitious sketch of a set of data with two types of variables: anonymised identiﬁer of the
farm and HIGH-RESOLUTION geo-coordinates (for illustrative purpose)
Dummy identiﬁer farm x y
1#uvhbwoh 45.64 7.27
2#vjenvijnb 45.71 7.29
3#ijvbirb 45.34 7.62
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The goal of this ﬂexibility is of course to make use of all possible information available at European
level. Certainly, the higher the resolution, the more sophisticated the analysis that is possible to run. A
spread model is a good example of a technique that would beneﬁt of highly resolved information to be
able to identify patterns, potential risk factors, etc. of a given disease, mainly because of the higher
quality (accuracy, completeness, uniformity across EU) of the input data.
In terms of ﬂexibility, it is also important to highlight that the r-ADM has a modular structure. This
means that at any time another set of information is required (e.g. the collection of data that are not
recorded in ofﬁcial registers and require manual input, like the data generated from a case–control study
in the ﬁeld) or another source of information is identiﬁed (e.g. the CORINE land cover data6), a new
component can be designed, inserted in the r-ADM and link it with the existing categories of data.
4.3. Compatible
The r-ADM should be as compatible as possible with international databases on animal health
data, namely: the ADNS from the European Commission, the EUROSTAT database, the Animal Disease
Information System (ADIS) – which is under development by the European Commission in collaboration
with the World Organisation for Animal Health (OIE) – the OIE’s World Animal Health Information System
(WAHIS) and the Global Animal Disease Information System EMPRES-I from FAO (see Figure 4).
This compatibility will allow EFSA to retrieve from these international databases all information of
interest, avoiding therefore, as much as possible, any type of duplication in data submission for the
MSs (see Section 2 and Figure 1).
4.4. Fit for purpose
The r-ADM, will integrate a great variety of heterogeneous data in a harmonised way. Overall, data
will be ﬁt for different types of analyses and purposes (see Figure 4). As an example, the
standardised collection of domestic and wild animal populations will support not only the epidemiological
analysis of animal disease outbreaks and a good variety of risk assessment approaches (including risk
factor analysis), but also the analysis related to the EFSA–ECDC zoonoses summary report (EFSA and
ECDC, 2017).
The suitability for different type of quantitative analyses will not be the only feature that the r-ADM
aims to bring to the animal disease risk assessment process. Indeed, having in place a data model
developed, discussed and agreed with all the MSs during ‘peace-time’ will increase EFSA’s
preparedness as: (i) the data can be submitted by the MSs on a regular basis in order to have at
any time an updated situation, e.g. of the affected populations; and (ii) in case an ad hoc submission
is required, e.g. upon urgent request to EFSA from the European Commission following an outbreak, it
will be much easier for the MSs to provide the data as the data ﬂow will be already in place. As a
result, EFSA will have higher quality data in a shorter time at its disposal and will be able to
provide timely replies to the European Commission, with beneﬁts to the concerned MSs as the
outbreak will be considered in its broader picture.
Table 2: Fictitious sketch of a set of ‘aggregate-able’ data, with two types of variables: anonymised
identiﬁer of the farm and LOW-RESOLUTION geo-coordinates (for illustrative purpose)
Dummy identiﬁer farm x y NUTS3
1#uvhbwoh – – Aosta
2#vjenvijnb – – Aosta
3#ijvbirb – – Torino
6 https://www.eea.europa.eu/publications/COR0-landcover
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Figure 4: r-ADM features in a glance. The r-ADM will result from the harmonisation of the existing
and ongoing data collection activities; will be compatible with the existing ofﬁcial
international databases; will be ﬂexible enough to gather data generated under different
programmes and at different level of resolutions; will be ﬁt for different purposes
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5. From the critical analysis to the solution: a stepwise approach
towards the SIGMA-ADM
5.1. Risk assessment requests/Terms of reference
As a ﬁrst step, in line with the EFSA Prometheus7,8 approach (EFSA, 2015), the scope of previous
risk assessments was reviewed. Fourteen mandates received from the European Commission since
2014 on the diseases under evaluation (ASF, LSD, AI and EM) were considered. Since 2014, EFSA
received a total of 14 mandates (4 on AI, 5 on ASF, 3 on EM and 3 on LSD) and issued a total of 34
outputs. The results of the systematic search can be found in Appendix D.
Particular attention was given to the Terms of Reference (ToRs) in the different mandates as they
represent the explicit questions to be addressed. The information was collected in an Excel database
to facilitate the interpretation (see Appendix E).
Each ToR was then classiﬁed in a Category of Epidemiological Question. As an example, one
of the ToRs in one of the mandates related to AI was to estimate/assess the probability that the virus
‘could be transmitted from wild birds to domestic bird holdings’. This question focusing on the
probability that the animal production industry could be affected by a novel disease was classiﬁed
under the ‘Probability of Introduction’ category. In Table 3, the identiﬁed Categories of Epidemiological
Questions are listed together with their frequency of occurrence. It emerged that the most frequent
question category to be addressed is the descriptive statistics. This outcome is not surprising as the
parameters included in the ‘descriptive statistics’ category (e.g. prevalence, incidence, etc.) constitute
the basis for more sophisticated analysis.
Next frequent categories refer to the assessment of the effectiveness of the sampling schemes
(9) and the risk factor analysis (9). Categories of Epidemiological Questions relating to the
effectiveness of countermeasures, biosecurity measures and protection measures together
sum up to 12.
5.2. Envisaged Analysis
The second step in the process, in line with the Prometheus approach, was to envisage the type
of statistical analysis/approaches and/or the parameters to be estimated to address a given
category of epidemiological question. In Table 4, typical statistical analyses/approaches are listed for
each Category of Epidemiological Questions. The full list of the proposed analyses and approaches,
together with the related description, is reported in Appendix F.
It should be noted that the list of purposeful analyses is not exhaustive, and the goal is to identify
the data worth collecting from the MSs. When the SIGMA project is running, and data ﬂows are
working, an ad hoc Plan of Analyses, based on the envisaged analyses, will be tailored to the set of
data actually available.
Table 3: Frequency of occurrence of epidemiological question category and per for each of the
diseases for which EFSA has a mandate
Epidemiological question category AI ASF EM LSD Total counts
Descriptive statistics 3 3 3 3 12
Effectiveness of biosecurity measures 2 1 3
Effectiveness of countermeasures 3 2 2 7
Effectiveness of protection measures 1 1 2
Effectiveness of sampling schemes 3 5 1 9
Impact assessment 1 1 2
Probability of endemicity 1 1
Probability of introduction 2 1 3
Risk factors analysis 2 2 3 2 9
Spread pattern analysis 1 1 2
Trend analysis 4 2 6
7 https://www.efsa.europa.eu/en/interactive_pages/prometheus/prometheus
8 http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2015.4121/epdf00
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5.3. Deﬁnition of the data needs
The third step in the Prometheus approach consists of the identiﬁcation of the data needs based
on the analyses, approaches identiﬁed in the previous step as well as associated parameters. The
categories of input data required to run the relevant analyses are listed in Table 4. The full list of the
input data categories and related deﬁnitions is reported in Appendix G.
Table 4: List of the identiﬁed Epidemiological Question Categories. For each category, the related
possible statistical analysis/approaches and the Category of Input Data have been listed
Epidemiological question
category
Possible statistical analysis/
approaches/parameters
Category of input data and
parameters
Descriptive statistics Count
Proportion
Prevalence
Rate
Relative risk/risk ratio
Odds/Odds ratio
Incidence
Distribution maps
Risk mapping
Time
Location
Species
Population size
Population composition
Cases
Effectiveness of sampling
schemes
Probability of detection
Freedom from disease
Time to ﬁrst detection
Scenario tree models
Simulation techniques
Relative risk
Time
Sampling scheme
Cases
Population size
Test diagnostic speciﬁcity
Test diagnostic sensitivity
Risk factors analysis Attack rates
Secondary attack rates
Relative risk
Incidence rate ratio
Odds ratio
(Population) attributable RISK
(Population) attributable fraction
Regression techniques
Risk mapping
Spatial regression models
Population
Location
Exposure
Time
Cases
Effectiveness of counter
measures
Odds ratio
Simulation techniques
Relative risk
Hazard rate
Time
Exposure
Cases
Population size
Population composition
Trend analysis Regression techniques prevalence Time population
Cases
Effectiveness of biosecurity
measures
Odds ratio
Relative risk
Simulation techniques
Time
Exposure
Cases
Population size
Population composition
Risk of introduction Probability of introduction
Simulation techniques
Time to ﬁrst detection
Animal movements
Place of origin
Prevalence
Cases
Population size
Diagnostic test speciﬁcity
Diagnostic test sensitivity
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5.4. Data Model building
Starting from the data needs, i.e. the list of input data categories (see Section 5.3), the r-ADM was
built following the steps listed below:
• Identiﬁcation of Entities and Relationships, where:
 ‘Entity’ is a database object capable to represent a thing in the real world, and can be
concrete, like ‘animal’ and ‘establishment’, or more abstract like ‘source’ and
‘programme type’;
 ‘Relationship’ is an association among two or more entities that are described by one of
three ratios (one-to-one, one-to-many, many-to-many), e.g. one establishment can
contain many sub-units.
• Identiﬁcation of the Attributes for each Entity, where an ‘Attribute’ is a characteristic of the
Entity (i.e. a column in the table) and can be of different types:
 Primary Key (PK) is an identiﬁer identifying univocally an entity (i.e. a record in a
table);
 Foreign Key (FK) is an attribute deﬁning a link to another entity (i.e. a record stored in
another table);
 all the other attributes further describe the entity modelled in the table and they can be
either unique or non-unique characteristics of an entity.
• Identiﬁcation, for each Attribute, of the possible Values, i.e.:
 the data type (e.g. text, number); the related Enumeration, in case the possible Values can be described with a reference
terminology (i.e. each value is taken from a controlled, agreed and predetermined list,
mutable over time).
For each entity, attribute and value identiﬁed, a deﬁnition was selected to make clear and
unequivocal the type of information that need to be collected.
It is important to stress that these deﬁnitions can be agreed with the data providers in the different
MSs without the need to impose, at MS level, the adoption of the same description or the
replacement of all deﬁnitions currently in use across EU. This is, in fact, one of the strengths of
the r-ADM: the descriptions reported in this document aim at having a common understanding, across
EU, of the variables of interest and not at ﬁnding a new name to be used at EU level in the future.
Epidemiological question
category
Possible statistical analysis/
approaches/parameters
Category of input data and
parameters
Effectiveness of protection
measures
Odds ratio
Vaccine effectiveness
Simulation techniques
Relative risk
Hazard rate
Exposure
Cases
Population size
Population composition
Vaccination status
Impact assessment Attack rates
Secondary attack rates
Case fatality rate
Incidence rate
Simulation techniques
Modelling techniques (e.g. S.I.R)
Population
Time
Cases
Spread pattern analysis Simulation techniques
Modelling techniques (e.g. S.I.R)
Transmission rate transmission kernel
Exposure
Population composition
Population
Location
Time
Cases
Probability of endemicity Simulations techniques
Modelling techniques (e.g. S.I.R)
Probability of freedom
Probability of transmission
Population
Vaccination
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Nevertheless, all deﬁnitions were submitted to the members of the Animal Health Network with the intent
to check if the r-ADM was comprehensive to cover all possible situations in the different MSs. At a later
stage, EFSA and the Consortium, will perform a data mapping exercise and the result will be a set of ‘data
dictionaries’ enabling EFSA to understand how the variables of interest are named in the different MSs,
translate them to make them ﬁt to the r-ADM and ﬁnally store them in the S-DWH.
The different deﬁnitions were not elaborated from scratch as this would have been a far too
theoretical approach. On the contrary, for each item, EFSA collected the existing deﬁnitions in the
European legislation in force. The extraction of the available legal deﬁnitions was the ground on which
the SIGMA deﬁnitions were built. After a thorough discussion, the EFSA ad hoc WG proposed a set of
deﬁnitions which are:
• The simple adoption of the deﬁnition as stands in the legislation and without any modiﬁcation
OR
• The synthesis of two or more deﬁnitions from two or more legal documents OR
• The modiﬁcation of an existing deﬁnition OR
• The creation of a new deﬁnition (in case no ofﬁcial deﬁnition was retrieved).
The following sections (from Sections 5.4.1–5.4.7), one per entity, provide the list of the ﬁnal
version of the deﬁnitions that will be used in the r-ADM. The full list of the legal references that were
consulted can be found in Appendix C, together with the major points of discussion.
As a general rule, the agreed deﬁnitions adhere as much as possible to the new Animal Health Law
(Regulation (EU) 2016/429 of the European Parliament and of the Council of 9 March 2016 on
transmissible animal diseases and amending and repealing certain acts in the area of animal health).
Only when the deﬁnitions were not present or did not describe exhaustively and unequivocally the item
of the r-ADM, EFSA took the initiative to modify those deﬁnitions, consult other legal references or to
create a new deﬁnition.
5.4.1. DATA MODEL SPECIFICATION
The following paragraphs describe the different entities and related attributes.
For each attribute, it is speciﬁed:
• ATTRIBUTE_NAME
• DATA TYPE: Attributes relaying on reference terminology contain as data type a reference to
an enumeration, further speciﬁed in Section 5.4.7.
• M/O: M stands for Mandatory and O for Optional
• KEY: Constraint type (if any) – it can be PK or FK
• DESCRIPTION.
Each entity is described as a single table, and also as a unique ﬂat table in Appendix A.
An Entity–Relationship diagram is presented in Appendix B and it also shows links to the SSD2 data
model which will be used to store monitoring/surveillance data mostly generated from laboratory
results. SSD2 is currently under revision and it will encompass also changes required by the SIGMA
project.
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5.4.2. ESTABLISHMENT
• SIGMA deﬁnition: Any premises, structure, or, in the case of open-air farming, any environment or place, where animals or germinal products are
kept, on a temporary or permanent basis, except for (a) households where pet animals are kept and (b) veterinary practices or clinics [Regulation
(EU) 2016/429 (AHL), art. 4(27)].
ATTRIBUTE NAME DATA TYPE M/O KEY DESCRIPTION
ESTABLISHMENT_ID xs:string(200) M PK Dummy identiﬁer OR ofﬁcial identiﬁer (according to the MS visibility policy) of the Establishment/
Holding. The standards may change according to the national relevant legislation
GEO_LOCATION_ID xs:string(200) M FK Identiﬁer of the record in the GEO_LOCATION table containing the location of the
Establishment
ESTABLISHMENT_TYPE EstablishmentTypeEnum M Type of Establishment, characterised by a speciﬁc aim and by a speciﬁc epidemiological role
MS: Member State; PK: Primary Key; FK: Foreign Key.
5.4.3. SUB_UNIT
• SIGMA deﬁnition: Management group of animals as part of an establishment.
• Examples: ﬂock, pen, herd, house, shed, etc.
ATTRIBUTE NAME DATA TYPE M/O KEY DESCRIPTION
SUB_UNIT_ID xs:string(200) M PK Dummy identiﬁer OR ofﬁcial identiﬁer (according to the MS visibility policy) of the sub-unit. The
standards may change according to the relevant national legislation
SUB_UNIT_UPDATEY xs:int(4) M Year – Date at which the information was generated (last update)
SUB_UNIT_UPDATEM xs:int(2) M Month – Date at which the information was generated (last update)
SUB_UNIT_UPDATED xs:int(2) M Day – Date at which the information was generated (last update)
ESTABLISHMENT_ID xs:string(200) M FK Dummy identiﬁer OR ofﬁcial identiﬁer (according to the MS visibility policy) of the Establishment to
which the Sub_unit belongs
GEO_LOCATION_ID xs:string(200) M Identiﬁer of the record in the GEO_LOCATION table containing the location of the Sub_unit
SPECIES SpeciesEnum M The common name, the genus, the species and the breed of the sub-unit of concern. This is
particularly relevant in the cases in which the single animals do not have an animal id
PRODUCTION_TYPE ProductionTypeEnum M Type of ﬁnal product of the Establishment OR aim for which the animals are kept and/or bred
CAPACITY xs:integer(6) M The capacity of the establishment, i.e. the permitted maximum number of animals that the
establishment can host. For some species, it can be, as an example, number of cubicles or pen places
ACTUAL_NUMBER xs:integer(6) M Number of animals at the date the information was generated (last update)
PK: Primary Key; FK: Foreign Key.
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5.4.4. KEPT_ANIMAL
• SIGMA deﬁnition: any terrestrial animal which is kept by humans and registered with a unique ID.
• Legal references: Regulation (EU) 2016/429 (AHL), art. 4(2), Regulation (EU) 2016/429 (AHL), art. 4(5).
ATTRIBUTE NAME DATA TYPE M/O KEY DESCRIPTION
KEPT_ANIMAL_ID xs:string(200) M PK Dummy identiﬁer OR ofﬁcial identiﬁer (according to the MS visibility policy) of the
individual kept animal (for the relevant species). The standards may change according to
the relevant legislation. [Commission Implementing Regulation (EU) 2017/949, art. 2]
KEPT_ANIMAL_UPDATEY xs:int(4) M Year – Date at which the information was generated (last update)
KEPT_ANIMAL_UPDATEM xs:int(4) M Month – Date at which the information was generated (last update)
KEPT_ANIMAL_UPDATED xs:int(4) M Day – Date at which the information was generated (last update)
ESTABLISHMENT_ID xs:string(200) M FK Dummy identiﬁer OR ofﬁcial identiﬁer (according to the MS visibility policy) of the
Establishment to which the animal belongs
SUB_UNIT_ID xs:string(200) M FK Dummy identiﬁer OR ofﬁcial identiﬁer (according to the MS visibility policy) of the
sub-unit to which the animal belongs
SPECIES SpeciesEnum (only
mammals)
M The common name, the genus, the species and the breed of the sub-unit of concern. This
is particularly relevant in the cases in which the single animals do not have an animal id
PRODUCTION_TYPE ProductionTypeEnum (only
related to mammals)
M Type of ﬁnal product of the Establishment OR aim for which the animals are kept and/or
bred
SEX GenderEnum M Sex of the kept animal
BIRTH_Y xs:int(4) O Year – Date of birth of the kept animal
BIRTH_M xs:int(2) O Month – Date of birth of the kept animal
BIRTH_D xs:int(2) O Day – Date of birth of the kept animal
BIRTH_ESTABLISHMENT_ID xs:string(200) O Dummy identiﬁer OR ofﬁcial identiﬁer (according to the MS visibility policy) of the
Establishment where the kept animal was born. The standards may change according to
the relevant legislation
BIRTH_SUB_UNIT_ID xs:string(200) O Dummy identiﬁer OR ofﬁcial identiﬁer (according to the MS visibility policy) of the
Sub_unit where the kept animal was born. The standards may change according to the
relevant legislation
BIRTH_COUNTRY xs:string(2) O ISO code of the country where the kept animal was born
MOTHER_ANIMAL_ID xs:string(200) O Dummy identiﬁer OR ofﬁcial identiﬁer (according to the MS visibility policy) of the mother
of the individual kept animal (for the relevant species). The standards may change
according to the relevant legislation. This attribute is logically a link referring the same
KEPT_ANIMAL table. As such is should be captured as FK, but since data of the referred
animal might not be contained in the same table (i.e. animal died or moved in a different
country prior to any data submission) the constraint is not strictly implemented
MS: Member State; PK: Primary Key; FK: Foreign Key.
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5.4.5. GEO_LOCATION
• SIGMA deﬁnition: positioning on the Earth of the unit of interest, i.e. an establishment or a single animal, at the highest available resolution.
ATTRIBUTE NAME DATA TYPE M/O KEY DESCRIPTION
GEO_LOCATION_ID xs:string(200) M PK Identiﬁer of the geographical location
COORD_PRECISION CoordPrecisionEnum O Precision of the provided coordinates
X_COORD xs:decimal O Longitude (degrees) E/W
Y_COORD xs:decimal O Latitude (degrees) N/S
ADDRESS xs:string(200) O Address of the located entity
ZIP_CODE xs:string(10) O ZIP code of the located entity
MUNICIPALITY xs:string(200) O Municipality of the located entity
NUTS3 NutsEnum M NUTS code level 3 of the located entity
PK: Primary Key.
5.4.6. DISEASE_DETECTION
• SIGMA deﬁnition: string of information related to the reporting of a possible outbreak as recorded in the ADNS (or in the ADIS, when available)
or, failing that, from other similar systems (WAHIS, EFSA DCF).
ATTRIBUTE NAME DATA TYPE M/O KEY DESCRIPTION
DISEASE_DETECTION_ID xs:string(200) M PK It is the outbreak/disease detection number as registered within the Country and reported to
the Commission (e.g. in ADNS)
GEO_LOCATION_ID xs:string(200) M Identiﬁer of the record in the GEO_LOCATION table containing the location of the disease
detection
DISEASE DiseaseEnum M Disease to be notiﬁed
SPECIES SpeciesEnum M The common name, the genus, the species and the breed of the sub-unit of concern. This is
particularly relevant in the cases in which the single animals do not have an animal id
PRODUCTION_TYPE ProductionTypeEnum M Type of ﬁnal product of the Establishment OR aim for which the animals are kept and/or bred
OUTBREAK_TYPE OutbreakTypeEnum M The type of outbreak (primary or secondary)
SUSPICION_DATEY xs:int(4) M Year – Date of suspicion of outbreak
SUSPICION_DATEM xs:int(2) M Month – Date of suspicion of outbreak
SUSPICION_DATED xs:int(2) M Day – Date of suspicion of outbreak
CONFIRMATION_DATEY xs:int(4) M Year – Date of conﬁrmation of outbreak
CONFIRMATION_DATEM xs:int(2) M Month – Date of conﬁrmation of outbreak
CONFIRMATION_DATED xs:int(2) M Day – Date of conﬁrmation of outbreak
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ATTRIBUTE NAME DATA TYPE M/O KEY DESCRIPTION
TYPE_SUBTYPE xs:string(200) O Comma separated of list disease type/subtype code
NR_SUSCEPTIBLE xs:int(4) O Number of total susceptible animal present at farm
NR_AFFECTED xs:int(4) O Number of affected animals (clinically affected or positive at diagnostic test) at conﬁrmation
date
NR_DEAD xs:int(4) O Number of dead animals at conﬁrmation date
NR_KILLED xs:int(4) O Number of animals killed at conﬁrmation date
NR_DESTROYED xs:int(4) O Number of carcases destroyed at conﬁrmation date
ADNS: Animal Disease Notiﬁcation System; PK: Primary Key.
5.4.7. ENUMERATION
All the enumerations will be implemented as catalogues in the reference terminology management system of EFSA, integrated with the DCF and enabling
automatic data validation.
Each enumeration might be either created as a new EFSA catalogue or implemented by extending an existing one.
ENUMERATION VALUE DESCRIPTION
EstablishmentTypeEnum Quarantine premises Establishment where the animals are kept in isolation with no direct or indirect contact with animals outside
this epidemiological unit, for the purpose of ensuring that there is no spread of one or more speciﬁed
diseases while the animals in isolation are undergoing observation for a speciﬁed length of time and, if
appropriate, testing and treatment. [based on Regulation (EU) 2016/429 (AHL), art. 4(38)]
EstablishmentTypeEnum Assembly centre Establishment, approved by the competent authority, where kept terrestrial animals are assembled from more
than one establishment for a period shorter than the required residency period for the species of animals
concerned, for NATIONAL and INTERNATIONAL movements
EstablishmentTypeEnum Market Establishment, registered by the competent authority, where kept terrestrial animals are assembled from
more than one establishment for a period shorter than the required residency period for the species of
animals concerned, for NATIONAL movements
EstablishmentTypeEnum Exhibition Permanent establishments where animals of domestic or wild species are kept for exhibition to the public for
7 or more consecutive days a year (e.g. zoos, petting centres), with the exception of circuses and pet shops.
EstablishmentTypeEnum Show Temporary events where animals of domestic or wild species are brought together for exhibition to the public
for less than 7 consecutive days a year
EstablishmentTypeEnum Farm Establishment where the animals are kept by humans, since birth OR for a rearing/production period OR for
the required residency period for the species of animals concerned, for commercial purposes, i.e. to breed
and/or rear and/or sell animals and/or products of animal origin. Hatcheries are excluded
EstablishmentTypeEnum Genetic centre Establishment where the animals (bovines, equines, swine, sheep, goats) are kept by humans, for the
collection of germinal products.
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ENUMERATION VALUE DESCRIPTION
EstablishmentTypeEnum Hatchery An establishment which incubates and hatches eggs and supplies day-old chicks (art 2, Council Directive
2009/158/EC of 30 November 2009 on animal health conditions governing intra-community trade in, and
imports from third countries of, poultry and hatching eggs)
EstablishmentTypeEnum Slaughtering centre Establishment used for slaughtering and dressing animals, the meat of which is intended for human
consumption OR establishment in which game and game meat obtained after hunting are prepared for
placing on the market. Stalls, pens, covered areas or ﬁelds associated with or part of slaughterhouse
operations are included
EstablishmentTypeEnum Health & Research centres Any permanent, geographically limited and approved establishment where one or more species of animal are
habitually: (i) kept for fundamental or applied scientiﬁc research; or (ii) bred for the purposes of such
research (iii) kept to undergo veterinary medicine practices. For example, research laboratories, veterinary
hospitals, etc.
EstablishmentTypeEnum Pasture/Co-pasture 2000/115 refers to land used for (common) grazing which is under the control of a local authority
ProductionTypeEnum Germinal products ‘Germinal products’ means: (i) semen, oocytes and embryos intended for artiﬁcial reproduction; (ii) hatching
eggs [Regulation (EU) 2016/429 (AHL), art. 4(27)]
ProductionTypeEnum Breeders ‘Breeders’ are animals of high genetic value kept for reproduction purposes. For example, grandparents and
parent ﬂocks (poultry); pedigree dams and sires; etc.
ProductionTypeEnum Meat/Fattening Rearing or keeping in captivity animals for the primary purpose of producing meat
ProductionTypeEnum Milk Rearing or keeping in captivity animals for the primary purpose of producing raw milk, i.e. milk produced by
the secretion of the mammary gland of farmed animals that has not been heated to more than 40C or
undergone any treatment that has an equivalent effect.
ProductionTypeEnum Eggs Rearing or keeping in captivity animals for the primary purpose of producing eggs, where ‘Eggs’ means
unfertilised eggs in shell – e.g broken, fresh table or cooked eggs – that are produced by farmed birds and
are ﬁt for direct human consumption or for the preparation of egg products AND technical purposes
(cosmetics)
ProductionTypeEnum SPF Animals or eggs which are used for diagnostic procedures in laboratories, for the production and testing of
vaccines and for research and pharmaceutical purposes
ProductionTypeEnum Foie-gras Rearing or keeping in captivity animals for the production of foie gras, where foie-gras means the livers of
geese, or of ducks of the species Cairina muschata or Cairina muschata x Anas platyrhynchos which have
been fed in such a way as to produce hepatic fatty cellular hypertrophy
ProductionTypeEnum Game Animals kept in captivity for restocking supplies of game animals
SpeciesEnum Mammals Mammals (and all subcategories)
SpeciesEnum Birds Birds (and all subcategories)
GenderEnum Female Female
GenderEnum Male Male
GenderEnum Mixed females and males Mixed females and males
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ENUMERATION VALUE DESCRIPTION
CoordPrecisionEnum Centroid admin Centroid of an administrative area (region or country)
CoordPrecisionEnum Centroid generic Coordinates indicating the centroid of a non-administrative area
CoordPrecisionEnum Exact Exact location XY coordinates of trap or point of sample
CoordPrecisionEnum Estimated Near location XY coordinates based on village, town or identiﬁable geographical feature (national park, lake,
river, etc.)
CoordPrecisionEnum Unknown Location Unknown
NutsEnum – Many – NUTS code, according to EUROSTAT. Information should be provided at least at NUTS level 3
DiseaseEnum HPAI poultry HPAI poultry
DiseaseEnum HPAI captive birds HPAI captive birds
DiseaseEnum HPAI wild birds HPAI wild birds
DiseaseEnum LPAI poultry LPAI poultry
DiseaseEnum LPAI captive birds LPAI captive birds
DiseaseEnum LPAI wild birds LPAI wild birds
DiseaseEnum LSD LSD
DiseaseEnum ASF ASF
DiseaseEnum Echinococcus multilocularis Echinococcus multilocularis
OutbreakTypeEnum Primary Primary
OutbreakTypeEnum Secondary Secondary
LSD: lumpy skin disease; ASF: African swine fever; HPAI: High Pathogenic Avian Inﬂuenza; LPAI: Low Pathogenic Avian Inﬂuenza.
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6. r-ADM (Relational structure)
The outcome of the three steps as outlined in the section dedicated to the data model building (see
Section 5.4) was a draft data model, ideally applicable to any type of pathogen and disease and ﬁtted in
order to gather data required for different statistical analyses and to ensure a good level of
harmonisation between MSs. Appendix B shows the structure of the ﬁrst draft of the SIGMA Data Model,
including the relationships between the different entities. Further details about entities, attributes and
values can be found in Section 5.4 and in Appendix C.
7. Testing the ﬁtness of the draft r-ADM
As described in Section 4 and Figure 2, the input data categories were checked against the data
models underpinning the current and ongoing data collections within the remit of the Animal Health
and Welfare team and of the Biological Hazards team.
Once the ﬁrst version of the r-ADM was drafted, this was circulated within EFSA to the relevant
project owners, dealing with the European Commission mandates on LSD, ASF, vector-borne diseases,
AI, EM and the zoonoses and zoonotic agents included in the relevant legislation. It conﬁrmed that the
type of information and the level of detail that r-ADM was designed to collect addressed the needs in
the requests of the different mandates received from the European Commission.
Nevertheless, it has to be made clear that the present version of the r-ADM will be potentially
subject to modiﬁcations and adaptations based on the feedback received by the SIGMA Consortium
during the implementation phase.
8. User case and beneﬁts
8.1. Animal Health and Welfare: the case of the avian inﬂuenza
The whole idea of the SIGMA project originated from a very pragmatic issue related to the
mandate in which EFSA was tasked with the provision of technical assistance regarding the ongoing AI
outbreak in 2017 (Question Number: EFSA-Q-2017-00229).
Considering that the AI epidemic in 2016–2017 has been one of the largest in terms of number of
poultry outbreaks, geographical spread and number of dead wild birds, the Terms of Reference (ToR)
in the mandate were understandably challenging. The European Commission requested EFSA to:
• analyse the epidemiological data on HPAI and LPAI, where co-circulating or linked within
the same epidemic, from HPAI disease affected MSs;
• analyse the temporal and spatial pattern of HPAI and LPAI as appropriate in poultry,
captive birds and wild birds, as well as the risk factors involved in the occurrence,
spread and persistence of HPAI viruses in these avian populations;
• based on the ﬁndings from the points above, describe the effect of prevention and control
measures;
• provide for regular quarterly reports updating on the AI situation within the Union and
worldwide, in particular with a view to describing the evolution of virus spread from
certain regions towards the EU. In case of signiﬁcant changes in the epidemiology of AAI,
these reports could be needed more frequently. These reports should, in particular, closely
follow the developments of zoonotic AI viruses, such as HPAI A(H5N6) and LPAI A(H7N9), in
collaboration with the European Centre for Disease Prevention and Control (ECDC).
In this framework, EFSA explored different European sources of information about poultry
demography (holdings, herds, ﬂocks, birds, species, etc.) at a sufﬁcient level of resolution (e.g.
NUTS3), but without success. This was expected as the data in the different EU systems (e.g.
EUROSTAT) are collected for other purposes than risk assessment.
EFSA was able to retrieve the data inserted by the MSs in the ADNS. Therefore, EFSA decided to ask
the MSs to complement those data with additional information on the holdings and or birds affected by
the disease. Considering the limited timeframe, it was not possible to put in place a web-based
application to standardise and validate the additional data required, which were ﬁnally submitted by
means of spreadsheet ﬁles. The latter lead to the identiﬁcation of the following issues:
• the spreadsheets were prone to human error; EFSA had to dedicate considerable resources to
validate the submitted data for consistency (internal-validation);
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• a certain variability across the MSs in the interpretation of the standard terminology was
recorded which required an intense communication between EFSA and the MSs to make the
data fully comparable (external validation).
At the end of the process, EFSA had a consistent set of data to perform the analysis. However,
these data were limited as only the affected holdings and birds were reported, without any detailed
information about the portion of the population of interest that was not affected by the disease,
therefore limiting the extent of the analyses that could be performed. The results that EFSA was able
to produce and the related discussion on their interpretation is available in the Scientiﬁc Report
published in collaboration with the ECDC and the European Union Reference Laboratory for Avian
Inﬂuenza (EFSA and ECDC, 20179), Section 3.1.4 (Characterisation of the HPAI-affected poultry
holdings (from October 2016 to April 2017)).
Another important aspect that has to be considered in relation to AI is the decision of the European
Commission, following the exit of the United Kingdom from the EU, to appoint EFSA as the responsible
body in charge of the development and the publication of the annual report on the AI surveillance
activity at EU level (M-2017-0221). The goal in this case is different from the quarterly report. In the
latter, the focus is on the evolution of the outbreaks, while in the former it is to actively monitor the
situation in each MS for early detection of new cases and/or strains through poultry and wild bird
surveillance. However, also in this case, the data submitted pertain only to the poultry premises that
were selected and tested in the monitoring programme. Therefore, once more, a detailed set of
information about the demography of the poultry population is missing and simple statistics like the
intensity of the sampling activity is rather difﬁcult to obtain, unless requested to each involved MS.
8.1.1. Beneﬁts of the r-ADM on the EFSA quarterly report and the Avian
Inﬂuenza surveillance report
In this context, the beneﬁts that the SIGMA project could bring are rather sensitive, both for EFSA
and the MSs; in brief:
• MSs could decide to automate the process of submitting data (previously transformed to ﬁt the
r-ADM with the help of the SIGMA Consortium). This would not only provide a validated and
consistent set of data but also reduce the effort needed for this recurrent exercise.
• These data have to be submitted only once and will serve for reporting on outbreaks,
surveillance activities and relevant zoonotic diseases (e.g. Salmonella).
8.2. Zoonotic agents: the case of ‘double reporting’ (see also
Appendix H)
In the context of the general zoonoses mandate, EFSA collects MS-speciﬁc data on animal
populations. However, certain of these animal population data are also collected from MS by the
European Commission (DG Sante: G2 unit ‘Animal health and welfare’ and D4 unit ‘Food safety
programme, emergency funding’), in the context of MSs’ control and eradication programmes that are
co-ﬁnanced by the European Commission. These data are alike, although not always identical because
of the different perspective they are collected for, and the compulsory requirement for MS to report
these to EFSA and to European Commission is underpinned by EU legislation. This issue is commonly
known as ‘double reporting’.
It has been estimated that, on average, the effort required by a MS to collect and to submit to
EFSA the relevant animal population data and manage them to ﬁt the requirement of EFSA is of one
person for one week. The collection, validation and submission of the complete zoonoses data sets
require several months resources for one person (two to three).
Regarding the data submission of data on zoonoses, currently only few MSs (four) transmit their
annual animal population in the zoonoses domain to EFSA without manual manipulation and are
extracted from national databases and transmitted to EFSA using XML. The majority of the MSs,
however, use an EFSA zoonoses Excel-based mapping tool where data are manually inserted ad
managed before sending to EFSA using an XML generating tool. The shaping up of data in the EFSA
9 European Food Safety Authority, European Centre for Disease Prevention and Control, European Union Reference Laboratory
for Avian inﬂuenza, Brown I, Mulatti P, Smietanka K,Staubach C, Willeberg P, Adlhoch C, Candiani D, Fabris C, Zancanaro G,
Morgado J and Verdonck F,2017. Scientiﬁc report on the avian inﬂuenza overview October 2016–August 2017. EFSA Journal
2017;15(10):5018, 101 pp. https://doi.org/10.2903/j.efsa.2017.5018
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mapping tool is very resource-intensive. In addition, the MSs transmit their annual animal population
data to the European Commission with manual input in a PDF tool with an embedded XML structure.
Another problem relates to the fact that the national reporters, submitting the relevant data to EFSA
and to the European Commission, are staff employed in different units or agencies and institutes which
might have slightly different objectives and missions. This may lead to some discrepancies across the
different reports: despite the data are the same, a different way of aggregating them may lead to
apparent differences, e.g. in counts and proportions. For this reason MSs, EFSA and the European
Commission carry out annually a thorough cross-validation exercise to ensure that no discrepant
statistics are published in the MSs’ national zoonoses reports, nor in the EFSA scientiﬁc reports, nor in the
reports published by the European Commission. This exercise is extremely demanding and requires a lot
of resources.
8.2.1. Beneﬁts of the SIGMA project in the ﬁeld of the zoonotic diseases
The SIGMA Data Model is ﬂexible and can deal with many different types of data, from sample-based
to aggregated data. The SSD2, which deﬁnes the standards to describe the information related to the
individual sample, is part of the SIGMA Data Model, which ﬁts the requirements of the EFSA DWH.
It is proposed that the MSs submit to EFSA using the relevant standards deﬁned by the SIGMA Data
Model all the data needed by EFSA and the European Commission as regards animal population in the
zoonoses domain. Once those data are submitted and stored in the DWH, all concerned parties, with
different levels of permission, will be able to access the relevant data to generate different types of
report. As an example, the MSs will be able to access their own data and generate the national reports
to be submitted to the European Commission or other type of reports for internal use; the European
Commission will be able to generate summaries and overviews based on speciﬁc needs. This possibility
will be implemented by means of web-based tools directly linked to the data stored in the EFSA DWH.
This solution will save a lot of time and resources to the MS which will have to submit only once
the data of concern, which will be available to EFSA and the European Commission for more than
one purpose. In addition, the data will be standardised at EU level. The only action required to the
MSs is to align the data submitted to EFSA with the SIGMA Data Model standards. However,
it has to be noted that this work is carried out by the SIGMA Consortium which is ﬁnanced
by EFSA.
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Glossary
Attribute A characteristic of the Entity which can be of different types: O Primary Key (PK)
attributes identify uniquely the entity; O Foreign Key (FK) attributes deﬁne relationships
between entities; O all the other attributes further describe the entity modelled in a table,
and they are non-unique characteristic of an entity
Entity A database object capable to represent a thing in the real world, and can be concrete,
like ‘animal’ and ‘establishment’, or more abstract like ‘source’, ‘geographical location’ and
‘programme type’
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Value A possible manifestation of the Attribute. It can be about: O the data type (e.g. text,
number); O the related Enumeration, in case the possible Values can be described with a
controlled list (a.k.a. reference terminology)
Abbreviations
ADIS Animal Disease Information System
ADNS Animal Disease Notiﬁcation System
AHL Animal Health Law
AI avian inﬂuenza
ASF African swine fever
BFSA Bulgarian Food Safety Agency
CDCP Country Data Collection Point
CSF Classical Swine Fever
DCF Data Collection Framework
DWH Data Warehouse
ECDC European Centre for Disease Prevention and Control
EFSA European Food Safety Authority
EM Echinococcus multilocularis
EUSR European Union Summary Report
ETl Extract-Transform-Load
FLI Friedrich Loefﬂer Institut
FK Foreign Key
HPAI High Pathogenic Avian Inﬂuenza
IT information technology
IZS Istituto Zooproﬁlattico Sperimentale
LPAI Low Pathogenic Avian Inﬂuenza
LSD lumpy skin disease
MS(s) Member State(s)
NCP National Contact Point
OIE World Organisation for Animal Health
OR Odds ratio
PK Primary Key
RAW Risk Assessment Workﬂow
RR Relative risk
S-DWH Scientiﬁc Data Warehouse
SVA Swedish National Veterinary Institute
WG Working Group
Ϭ-ADM SIGMA – Animal Data Model
TOR Terms of Reference
WAHIS World Animal Health Information System
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Appendix A – Full data model (ﬂat)
The following table describes how demographic data could be reported by joining all the tables of
the relational schema into a single ﬂat table.
The table does not contain Foreign Keys (FKs) attributes since they are not required when data are
provided in a de-normalised way (i.e. by replicating the information of the ESTABLISHMENT and of the
SUB_UNIT for each animal).
The entities described in the ﬂat DEMOGRAPHIC_DATA table are:
• E: ESTABLISHMENT
• EGL: GEOLOCATION of the ESTABLISHMENT
• SU: SUB UNIT
• SUGL: GEOLOCATION of the SUB UNIT
• KA: KEPT ANIMAL (all attributes related to the animal are not mandatory due to the fact that
not all the animals are individually registered, e.g. poultry)
For the scope note related to the single value of an enumeration please refer to the description in
chapter 5.
E ATTRIBUTE NAME DATA TYPE M/O ENUM VALUES DESCRIPTION
E ESTABLISHMENT_ID xs:string(200) M Dummy identiﬁer OR
ofﬁcial identiﬁer
(according to the MS
visibility policy) of the
Establishment/Holding.
The standards may
change according to
the national relevant
legislation
E ESTABLISHMENT_TYPE EstablishmentTypeEnum M Quarantine premises
Assembly centre
Market
Exhibition
Show
Farm
Genetic centre
Hatchery
Slaughtering Centre
Health & Research
centres
Pasture/Co-pasture
Type of Establishment,
characterised by a
speciﬁc aim and by a
speciﬁc epidemiological
role
EGL ESTABLISHMENT_
COORD_
PRECISION
CoordPrecisionEnum O Centroid admin
Centroid generic
Exact
Estimated
Unknown
Precision of the
provided coordinates
EGL ESTABLISHMENT_
X_COORD
xs:decimal O Longitude (degrees)
E/W
EGL ESTABLISHMENT_
Y_COORD
xs:decimal O Latitude (degrees) N/S
EGL ESTABLISHMENT_
ADDRESS
xs:string(200) O Address of the located
entity
EGL ESTABLISHMENT_
ZIP_CODE
xs:string(10) O ZIP code of the located
entity
EGL ESTABLISHMENT_
MUNICIPALITY
xs:string(200) O Municipality of the
located entity
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E ATTRIBUTE NAME DATA TYPE M/O ENUM VALUES DESCRIPTION
EGL ESTABLISHMENT_
NUTS3
NutsEnum M NUTS code,
according to
EUROSTAT.
Information should
be provided at least
at NUTS level 3
NUTS code level 3 of
the located entity
SU SUB_UNIT_ID xs:string(200) M Dummy identiﬁer OR
ofﬁcial identiﬁer
(according to the MS
visibility policy) of the
sub-unit. The standards
may change according
to the relevant national
legislation
SU SUB_UNIT_UPDATEY xs:int(4) M Year – Date at which
the information was
generated (last
update)
SU SUB_UNIT_UPDATEM xs:int(2) M Month – Date at which
the information was
generated (last
update)
SU SUB_UNIT_UPDATED xs:int(2) M Day – Date at which
the information was
generated (last
update)
SU SPECIES SpeciesEnum M Mammals (and all
subcategories)
Birds (and all
subcategories)
The common name,
the genus, the species
and the breed of the
sub-unit of concern.
This is particularly
relevant in the cases in
which the single
animals do not have an
animal id
SU PRODUCTION_TYPE ProductionTypeEnum M Germinal products
Breeders
Meat/Fattening
Milk
Egg
SPF
Foie-gras
Game
Type of ﬁnal product of
the Establishment OR
aim for which the
animals are kept and/or
bred
SU CAPACITY xs:integer(6) M The capacity of the
establishment, i.e. the
permitted maximum
number of animals that
the establishment can
host. For some species,
it can be, as an
example, number of
cubicles or pen places
SU ACTUAL_NUMBER xs:integer(6) M Number of animals at
the date the
information was
generated (last
update)
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E ATTRIBUTE NAME DATA TYPE M/O ENUM VALUES DESCRIPTION
SUGL SUB_UNIT_COORD_
PRECISION
CoordPrecisionEnum O Centroid admin
Centroid generic
Exact
Estimated
Unknown
Precision of the
provided coordinates
SUGL SUB_UNIT_X_COORD xs:decimal O Longitude (degrees)
E/W
SUGL SUB_UNIT_Y_COORD xs:decimal O Latitude (degrees) N/S
SUGL SUB_UNIT_ADDRESS xs:string(200) O Address of the located
entity
SUGL SUB_UNIT_ZIP_CODE xs:string(10) O ZIP code of the located
entity
SUGL SUB_UNIT_
MUNICIPALITY
xs:string(200) O Municipality of the
located entity
SUGL SUB_UNIT_NUTS3 NutsEnum M NUTS code,
according to
EUROSTAT.
Information should
be provided at least
at NUTS level 3
NUTS code level 3 of
the located entity
KA KEPT_ANIMAL_ID xs:string(200) O Dummy identiﬁer OR
ofﬁcial identiﬁer
(according to the MS
visibility policy) of the
individual kept animal
(for the relevant
species). The standards
may change according
to the relevant
legislation.
[Commission
Implementing
Regulation (EU) 2017/
949, art. 2]
KA KEPT_ANIMAL_UPDATEY xs:int(4) O Year – Date at which
the information was
generated (last
update)
KA KEPT_ANIMAL_UPDATEM xs:int(4) O Month – Date at which
the information was
generated (last
update)
KA KEPT_ANIMAL_UPDATED xs:int(4) O Day – Date at which
the information was
generated (last
update)
KA SPECIES SpeciesEnum O Mammals (and all
subcategories)
The common name,
the genus, the species
and the breed of the
sub-unit of concern.
This is particularly
relevant in the cases in
which the single
animals do not have an
animal id
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E ATTRIBUTE NAME DATA TYPE M/O ENUM VALUES DESCRIPTION
KA PRODUCTION_TYPE ProductionTypeEnum O Germinal products
Breeders
Meat/Fattening
Milk
SPF
Type of ﬁnal product of
the Establishment OR
aim for which the
animals are kept and/or
bred
KA SEX GenderEnum O Female
Male
Mixed females and
males
Sex of the kept animal
KA BIRTH_Y xs:int(4) O Male Year – Date of birth of
the kept animal
KA BIRTH_M xs:int(2) O Mixed females and
males
Month – Date of birth
of the kept animal
KA BIRTH_D xs:int(2) O Day – Date of birth of
the kept animal
KA BIRTH_ESTABLISHMENT_
ID
xs:string(200) O Dummy identiﬁer OR
ofﬁcial identiﬁer
(according to the MS
visibility policy) of the
Establishment where
the kept animal was
born. The standards
may change according
to the relevant
legislation
KA BIRTH_SUB_
UNIT_ID
xs:string(200) O Dummy identiﬁer OR
ofﬁcial identiﬁer
(according to the MS
visibility policy) of the
Sub_unit where the
kept animal was born.
The standards may
change according to
the relevant legislation
KA BIRTH_COUNTRY xs:string(2) O ISO code of the
country where the kept
animal was born
KA MOTHER_ANIMAL_ID xs:string(200) O Dummy identiﬁer OR
ofﬁcial identiﬁer
(according to the MS
visibility policy) of the
mother of the individual
kept animal (for the
relevant species). The
standards may change
according to the
relevant legislation
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Appendix B – Entity Relationship diagram (relational model)
The diagram shows the entities related to the ADM. The monitoring data are only partially
described since they are extensively described in the SSD2 guidance.
Legend: PK: Primary Key; FK: Foreign Key. Green: demographic data; Orange: monitoring data; Red: Disease notiﬁcations.
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Appendix C – Legal references, discussions, justiﬁcations and reasoning
Appendix C provides a set of deﬁnitions found in different types of documents (EU legislation, EU guidelines OIE terrestrial code) that they were
considered to be adapted for the entities and attributes of the r ADM. In some cases, the deﬁnitions are controversial not clear enough and not able to ﬁt
the purposes of a consistent analysis of the data. The deﬁnition adopted in the r ADM (see Section 5.4) is either:
• The simple adoption of the deﬁnition as stands in the legislation and without any modiﬁcation OR
• The synthesis of two or more deﬁnitions from two or more legal documents OR
• The modiﬁcation of an existing deﬁnition OR
• The creation of a new deﬁnition (in case no ofﬁcial deﬁnition was retrieved).
1. ESTABLISHMENT
Initially, one of the most important entities identiﬁed to describe the animal population of interest was the Holding. However, it appeared that the
deﬁnition of ‘Establishment’ in the AHL was much more in line with what the EFSA’s epidemiologists need to perform statistical analysis and risk assessment,
i.e. that entity, characterised by a single geographical location point, where animals are grouped for a given scope. In fact, a ‘holding’ can be associated to
more than one geographical location point, as it may consist of two or more buildings, not necessarily located in the same place.
Commission Regulation (EU) 206/2010 (Def ID1) did not ﬁt the purpose as it includes wildlife and hunting reserves, which, in SIGMA, are kept
separated. The other three references (Def ID2, 3 and 4) could actually ﬁt, but considering the point above, instead of choosing among those three
deﬁnitions, EFSA decided to adhere to the Animal Health Law (AHL) deﬁnition of ‘Establishment’.
Def ID# LEGAL REFERENCE DEFINITION
1 Regulation (EU) 2016/429 (AHL), art. 4(27) ‘establishment’ means any premises, structure, or, in the case of open-air farming, any
environment or place, where animals or germinal products are kept, on a temporary or
permanent basis, except for: (a) households where pet animals are kept; (b) veterinary
practices or clinics
2 Commission Regulation (EU) 206/2010, art. 2 (ungulates, Equidae) ‘Holding’ means a farm or other ofﬁcially supervised agricultural, industrial or commercial
undertaking, including zoos, amusement parks and wildlife or hunting reserves where live
animals are regularly kept or bred
3 Regulation (EC) 1760/2000, art. 2 (bovines) ‘Holding’ means any establishment, construction or, in the case of an open-air farm, any
place situated within the territory of the same Member State, in which animals covered
by this Regulation are held, kept or handled
4 Council Directive 92/65/EEC, art 2 Any permanent, geographically limited establishment where one or more species of
animal are habitually kept or bred, whether or not for commercial ends, and exclusively
for one or more of the following purposes [omissis]
5 Council Directive 82/894/EEC, art. 2(a) ‘holding’ means any establishment (agricultural or other) situated in the territory of a
Member State, in which animals are reared or kept
6 Council Directive 92/119/EEC, art 2(1) Holding: any establishment (agricultural or other), situated in the territory of a Member
State, in which animals are kept or bred
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2. ESTABLISHMENT_TYPE (under ESTABLISHMENT)
No legal reference was found for this Attribute of the Establishment.
This is an overarching category, encompassing all relevant type of activities, each characterised by a speciﬁc epidemiological role. It is possible that not
all activities are captured under this Attribute. However, it was believed by EFSA that this list should cover the vast majority of the activities in place where
there is an interaction between humans and animals. In addition, often, minor activities (e.g. backyard) are not ofﬁcially recorded in the national databases,
making the data retrieval impossible or very difﬁcult. EFSA is still interested in these kind of information, as the role of these minor activities has not been
yet clariﬁed in full, but it is outside the scope of this project to include those data which may be retrieved by other means. Should these activities, at a
certain point in time, be ofﬁcially recorded following a new or a modiﬁed legislation, the Ϭ-ADM will be ready to include them.
3. QUARANTINE PREMISES (under ESTABLISHMENT – ESTABLISHMENT_TYPE)
Def ID# LEGAL REFERENCE DEFINITION
1 Regulation (EU) 2016/429 (AHL), art. 4(38) ‘Quarantine’ means the keeping of animals in isolation with no direct or indirect contact with animals
outside the epidemiological unit, for the purpose of ensuring that there is no spread of one or more
speciﬁed diseases while the animals in isolation are undergoing observation for a speciﬁed length of
time and, if appropriate, testing and treatment
The AHL deﬁnes in Art. 4 (38) what is ‘Quarantine’. With the Ϭ-ADM, beyond the activity itself, EFSA wants to collect information on the recorded
establishment dedicated to this activity. For this reason, the deﬁnition in the Ϭ-ADM was slightly modiﬁed specifying that the target is, indeed, the
premises dedicated to quarantine the animals.
4. ASSEMBLY CENTRE (under ESTABLISHMENT – ESTABLISHMENT_TYPE)
Agreed deﬁnition: Establishment, approved by the competent authority, where kept terrestrial animals are assembled from more than one
establishment for a period shorter than the required residency period for the species of animals concerned.
Def ID# LEGAL REFERENCE DEFINITION
1 Regulation (EU) 2016/429 (AHL), art. 4(49) ‘assembly operation’ means the assembling of kept terrestrial animals from more than one
establishment for a period shorter than the required residency period for the species of animals
concerned
2 Council Directive 64/432/EEC, art. 2(2)(o) (bovines, swine) Holdings, collection centres and markets, at which bovine animals or swine originating from
different holdings are grouped together to form consignments of animals intended for trade. These
assembly centres must be approved for trading purposes and meet the requirements laid down in
Article 11
3 Council Directive 2003/50/EC, art. 1(b)10 Premises on which ovine or caprine animals originating from different holdings are grouped
together to form consignments of animals intended for intra-Community trade;
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Def ID# LEGAL REFERENCE DEFINITION
4 Council Directive 91/68/EEC, art. 2(9) (ovine, caprine) Any place, other than the holding, where ovine or caprine animals are sold, bought and/or
assembled or loaded, and which complies with Article 3 (7) of Directive 64/432/EEC and Article 5
(1) (b) (i) of Directive 90/425/EEC for approved markets or assembly centres
The assembly centre was among one of the most debated deﬁnitions as the existing legislation was either too broad (e.g. merging assembly centres and
markets, which EFSA wanted to keep separated) and/or lacking a sharp deﬁnition on the maximum time an animal can be kept in such centres. Last, it was
important to distinguish between national and international movements. The deﬁnition in the Ϭ-ADM covers all these aspects.
5. MARKET (under ESTABLISHMENT – ESTABLISHMENT_TYPE)
Agreed deﬁnition: Establishment, registered by the competent authority, where kept terrestrial animals are assembled from more than one
establishment for a period shorter than the required residency period for the species of animals concerned, for NATIONAL movements.
Def ID# LEGAL REFERENCE DEFINITION
1 Council Directive 91/68/EEC, art. 2(9) (ovine, caprine) Approved market or assembly centre means any place, other than the holding, where ovine or
caprine animals are sold, bought and/or assembled or loaded, and which complies with Article 3
(7) of Directive 64/432/EEC and Article 5 (1) (b) (i) of Directive 90/425/EEC for approved markets
or assembly centres
2 UK 1990 No. 2628 (The Welfare of Animals at Markets
Order 1990)
Market place or sale-yard or any other premises or place to which animals are brought from other
places and exposed for sale and includes any lairage adjoining a market and used in connection
with it and any place adjoining a market used as a parking area by visitors to the market for
parking vehicles
3 OIE Terrestrial code (Glossary) MARKET means a place where animals are assembled for the purpose of trade or sale.
This deﬁnition is the outcome of the discussion made on the ‘Assembly centres’. Indeed, the two deﬁnitions are basically the same (e.g. regarding the
time an animal can spend in such premises), except for the nature of the movements which, in this case, are only within the country of origin. Other
deﬁnitions in the existing legislation didn’t help in having a consistent description of the type of establishments needed in the Ϭ-ADM, particularly
considering their different epidemiological role.
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6. EXHIBITION (under ESTABLISHMENT – ESTABLISHMENT_TYPE)
Agreed deﬁnition: Permanent establishments where animals of domestic or wild species are kept for exhibition to the public for 7 or more days a year,
with the exception of circuses and pet shops (e.g. zoos, petting centres).
Def ID# LEGAL REFERENCE DEFINITION
1 Council Directive 1999/22/EC, art.2 ‘zoos’ means all permanent establishments where animals of wild species are kept for exhibition to
the public for 7 or more days a year, with the exception of circuses, pet shops and establishments
which Member States exempt from the requirements of this Directive on the grounds that they do
not exhibit a signiﬁcant number of animals or species to the public and that the exemption will not
jeopardise the objectives of this Directive
In this case, the existing deﬁnition in the relevant directive was considered to be ﬁtting the purpose and was adopted almost without modiﬁcations. The
second part of the deﬁnition (related to the exemption) was not included in the Ϭ-ADM as implicit in the deﬁnition of ‘Establishment’, i.e. ofﬁcially authorised
and recorded in a national database.
7. SHOW (under ESTABLISHMENT – ESTABLISHMENT_TYPE)
Agreed deﬁnition: Temporary events where animals of domestic or wild species are kept for exhibition to the public for less than 7 consecutive days a
year.
Def ID# LEGAL REFERENCE DEFINITION
1 Council Directive 1999/22/EC, art.2 ‘zoos’ means all permanent establishments where animals of wild species are kept for exhibition to
the public for 7 or more days a year, with the exception of circuses, pet shops and establishments
which Member States exempt from the requirements of this Directive on the grounds that they do
not exhibit a signiﬁcant number of animals or species to the public and that the exemption will not
jeopardise the objectives of this Directive
It was important to distinguish between the temporary assemble of animals for a short period from the permanent presence of animals over time. In this
case, it was decided to make this distinction upon the duration of the event, i.e. more or less than 7 consecutive days a year.
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8. FARM (under ESTABLISHMENT - ESTABLISHMENT_TYPE)
Agreed deﬁnition: Establishment where the animals are kept by humans, since birth OR for a rearing/production period OR for the required residency
period for the species of animals concerned, for commercial purposes i.e. to breed and/or rear and/or sell animals and/or products of animal origin.
Hatcheries are EXCLUDED.
Def ID# LEGAL REFERENCE DEFINITION
1 Regulation (EU) 2016/429 (AHL), art. 4 ‘establishment’ means any premises, structure, or, in the case of open-air farming, any environment or
place, where animals or germinal products are kept, on a temporary or permanent basis, except for:
(a) households where pet animals are kept;
(b) veterinary practices or clinics;
2 Regulation (EU) 2016/429 (AHL), art. 4(49) ‘assembly operation’ means the assembling of kept terrestrial animals from more than one
establishment for a period shorter than the required residency period for the species of animals
concerned
3 Regulation (EU) 2016/429 (AHL), art. 4(5) ‘kept animals’ means animals which are kept by humans, including, in the case of aquatic animals,
aquaculture animals;
4 Regulation (EU) 2016/429 (AHL), art. 4(29) ‘products of animal origin’ means:
(a) food of animal origin, including honey and blood;
(b) live bivalve molluscs, live echinoderms, live tunicates and live marine gastropods, intended for
human consumption; and
(c) animals other than those referred to in point (b) intended to be prepared with a view to being
supplied live to the ﬁnal consumer;
5 Zoonoses catalogue for sampling point (place of primary production and the basic unit in agriculture)
Primary production premises
The best existing deﬁnition was probably the one in the Zoonoses catalogue (Def ID4), but EFSA wanted to give more details on the residency period
and on the description of the production type. Note that it was ﬁnally decided to keep the hatcheries out of this category.
9. GENETIC CENTRE (under ESTABLISHMENT - ESTABLISHMENT_TYPE)
Agreed deﬁnition: Establishment where the animals (bovines, equines, swine, sheep, goats) are kept by humans, for the collection of germinal
products.
Def ID# LEGAL REFERENCE DEFINITION
Regulation (EU) 2016/429 (AHL), art. 4(5) ‘kept animals’ means animals which are kept by humans, including, in the case of aquatic animals,
aquaculture animals;
Regulation (EU) 2016/429 (AHL), art. 4(49) ‘assembly operation’ means the assembling of kept terrestrial animals from more than one
establishment for a period shorter than the required residency period for the species of animals
concerned
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Def ID# LEGAL REFERENCE DEFINITION
Regulation (EU) 2016/429 (AHL), art. 4(28) ‘germinal products’ means:
(a) semen, oocytes and embryos intended for artiﬁcial reproduction;
(b) hatching eggs;
Regulation (EU) 2016/1012 Of The European Parliament
And Of The Council, art. 2(26)
‘breeding programme’ means a set of systematic actions, including recording, selection, breeding
and exchange of breeding animals and their germinal products, designed and implemented to
preserve or enhance desired phenotypic and/or genotypic characteristics in the target breeding
population
Regulation (EU) 2016/1012 Of The European Parliament
And Of The Council, art. 2(2)
‘breed’ means a population of animals sufﬁciently uniform to be considered to be distinct from other
animals of the same species by one or more groups of breeders which have agreed to enter those
animals in breeding books with details of their known ascendants for the purpose of reproducing
their inherited characteristics by way of reproduction, exchange and selection within the framework
of a breeding programme;
In this case, the AHL helped in limiting the discussion as the deﬁnition of germinal product was very clear. Note that the ‘hatching eggs’ are part of the
germinal products, therefore the establishments were these eggs are produced should fall under this category.
10. HATCHERY (ESTABLISHMENT – ESTABLISHMENT_TYPE)
a) Agreed deﬁnition: An establishment where eggs are hatched under artiﬁcial conditions. It may be used for ex-situ conservation purposes, i.e. to breed
rare or endangered species under controlled conditions; alternatively, it may be for economic reasons (i.e. to enhance food supplies).
Def ID# LEGAL REFERENCE DEFINITION
Council Directive 2009/158/EC, art. 2(9d) An establishment which incubates and hatches eggs and supplies day-old chicks
11. SLAUGHTERING CENTRE (under ESTABLISHMENT - ESTABLISHMENT_TYPE)
Agreed deﬁnition: Establishment used for slaughtering and dressing animals, the meat of which is intended for human consumption OR establishment
in which game and game meat obtained after hunting are prepared for placing on the market. Stalls, pens, covered areas or ﬁelds associated with or part
of slaughterhouse operations are included.
Def ID# LEGAL REFERENCE DEFINITION
1 REGULATION (EC) No 853/2004, APPENDIX I (1.16) “Slaughterhouse” means an establishment used for slaughtering and dressing animals, the meat of
which is intended for human consumption
2 Council Regulation (EC) No 1099/2009, art. 2(c) “Lairaging” means keeping animals in stalls, pens, covered areas or ﬁelds associated with or part
of slaughterhouse operations;
3 Regulation 853/2004 – Appendix I (1.18) “Game-handling establishment” means any establishment in which game and game meat obtained
after hunting are prepared for placing on the market
SIGMA Animal Disease Data Model: a comprehensive approach
www.efsa.europa.eu/efsajournal 36 EFSA Journal 2019;17(1):5556
Def ID# LEGAL REFERENCE DEFINITION
4 OIE Animal Health Code (Glossary) LAIRAGE means pens, yards and other holding areas used for accommodating animals in order to
give them necessary attention (such as water, feed, rest) before they are moved on or used for
speciﬁc purposes including slaughter
Bearing in mind that the priority of the Ϭ-ADM was to identify and locate establishments with a speciﬁc epidemiological role, EFSA considered
superﬂuous and artiﬁcial to split all the operations related to the production of meat into different categories and also to distinguish between domestic
animals and game. For this reason, the ﬁnal choice was for a more comprehensive deﬁnition which could include wild and domestic and all activities related
to the production of meat.
12. HEALTH & RESEARCH CENTRE (under ESTABLISHMENT – ESTABLISHMENT_TYPE)
Agreed deﬁnition: Any permanent, geographically limited and approved establishment where one or more species of animal are habitually:
• kept to perform basic or applied scientiﬁc research; or
• bred for the purposes of such research
• kept to undergo veterinary medicine practices
(e.g. research laboratories, veterinary hospitals, etc.)
Def ID# LEGAL REFERENCE DEFINITION
1 Council Directive 92/65/EEC, art 2(c) ‘approved body, institute or centre’ means any permanent, geographically limited establishment,
approved in accordance with Article 13, where one or more species of animal are habitually kept
or bred, whether or not for commercial ends, and exclusively for one or more of the following
purposes:
— display of the animals and education of the public
— conservation of the species;
— basic or applied scientiﬁc research or breeding of animals for the purposes of such research;
2 Regulation (EU) 2016/429 (AHL), art. 4(27) ‘establishment’ means any premises, structure, or, in the case of open-air farming, any
environment or place, where animals or germinal products are kept, on a temporary or permanent
basis, except for:
(a) households where pet animals are kept;
(b) veterinary practices or clinics;
In this case, the AHL on its own did not help in deﬁning the required information. In fact, Art. 4(27) excludes the premises where those activities are
performed from the deﬁnition of ‘Establishment’. It was of course impossible to explore the intentions of the legislator which might have taken into
consideration also political aspects, which are outside the scope of the Ϭ-ADM. For this reason and considering the common epidemiological role, it was
agreed to group under this deﬁnition the premises where research and veterinary practices are performed.
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13. SUB-UNIT
Agreed deﬁnition: Management group of animals as part of an establishment.
Def ID# LEGAL REFERENCE DEFINITION
1 COUNCIL DIRECTIVE 2007/43/EC, art. 2(g) ‘house’ means a building on a holding where a ﬂock of chickens are kept;
2 COUNCIL DIRECTIVE 2007/43/EC, art. 2(j) ‘ﬂock’ means a group of chickens which are placed in a house of a holding and are present in this
house at the same time;
3 [MISSING LEGAL REFERENCE] ‘pen’ [MISSING DEFINITION]
4 Zoonoses manual ‘herd’ means an animal or group of animals kept on a holding as an epidemiological unit
(Regulation (EC) No 2160/2003); if more than one herd is kept on a holding, each of these herds
shall form a distinct unit and shall have the same health status (Directive 64/432/EEC)
5 Regulation (EU) 2016/429 (AHL), art. 4(37) ‘compartment’ means an animal subpopulation contained in one or more establishments and, in
the case of aquatic animals, in one or more aquaculture establishments, under a common
biosecurity management system with a distinct health status with respect to a speciﬁc disease or
speciﬁc diseases subject to appropriate surveillance, disease control and biosecurity measures;
6 Regulation (EU) 2016/429 (AHL), art. 84 ‘epidemiological unit’ means a group of animals with the same likelihood of exposure to a disease
agent;
One of the most difﬁcult entities to describe was, indeed, the sub-unit. The EFSA expert had clear what the required information was about, but the
existing deﬁnitions did not entirely ﬁt the needs. EFSA were looking for a common term to identify those entities within an Establishment which contain one
or more groups of animals, whether or not separated by biosecurity measures. The closest deﬁnition is probably the ‘house’ (see Def ID1). However, this
deﬁnition would be ﬁtting the poultry Establishments only and, in addition, the legislation refers to ‘buildings within a Holding’: by its nature a ‘Holding’ can
encompass houses that are located all over a country and this was not in line with what EFSA was looking for (see in this Appendix Deﬁnition and
Discussion about ‘Establishment’). The deﬁnition of ‘Compartment’ and ‘Epidemiological unit’ were found to have a too heavy epidemiological connotation
and, in both cases, there could have been the same issue as for the ‘house’. In addition, the term ‘house’ is apparently linked to the avian species and in
this sense is too restrictive for the purpose. As a conclusion, EFSA preferred to use a generic term to make clear that the entity of interest, can consist of
any type of group of animals within an ‘Establishment’. As a consequence, the ‘Establishment’ and its ‘sub-units’ share the same geographical location. It is
irrelevant if the ‘sub-units’ have the same type of production, the same level of biosecurity or not.
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14. GERMINAL PRODUCTS (under SUB-UNIT – PRODUCTION TYPE)
Agreed deﬁnition: ‘germinal products’ means: (i) semen, oocytes and embryos intended for artiﬁcial reproduction; (ii) hatching eggs.
Def ID# LEGAL REFERENCE DEFINITION
Regulation (EU) 2016/429 (AHL), art. 4(27) ‘germinal products’ means: (i) semen, oocytes and embryos intended for artiﬁcial reproduction; (ii)
hatching eggs;
Council Directive 64/432/EEC, art 2(c) ‘animals for breeding or production’ means bovine animals (including the species Bison bison and
Bubalus bubalus) and swine other than those referred to in (b), including those intended for
breeding, milk or meat production, or draft purposes, shows or exhibition with the exception of
animals taking part in cultural and sporting events;
Council Directive 2009/158/EC, art. 2(4) ‘breeding poultry’ means poultry 72 h old or more, intended for the production of hatching eggs;
No discussion. The decision was to adhere to the Animal Health Law deﬁnition.
15. MEAT/FATTENING (under SUB-UNIT – PRODUCTION TYPE)
Agreed deﬁnition: Rearing or keeping in captivity animals for the primary purpose of producing meat.
Def ID# LEGAL REFERENCE DEFINITION
Council Directive 64/432/EEC, art 2(c) ‘animals for breeding or production’ means bovine animals (including the species Bison bison and
Bubalus bubalus) and swine other than those referred to in (b), including those intended for
breeding, milk or meat production, or draft purposes, shows or exhibition with the exception of
animals taking part in cultural and sporting events;
Regulation (EU) 2016/429 (AHL), art. 4(9) ‘poultry’ means birds that are reared or kept in captivity for:
(a) the production of:
(i) meat;
(ii) eggs for consumption;
(iii) other products;
Regulation (EC) No 853/2004 Of The European Parliament
And Of The Council, Annex I, art. 1.1
“Meat” means edible parts of the animals referred to in points 1.2 to 1.8 (domestic ungulates,
poultry, lagomorphs, wild game, farmed game, small wild game, large wild game), including blood
Zoonoses manual Meat production animals (bovines) - bovine animals, other than calves, kept exclusively for the
production of meat and including cows, heifers and bulls
There were no major problems with the deﬁnition of this type of production. Note that EFSA decided to insert the term ‘primary purpose’ as there are
cases where the establishment may put on the market other categories of products, but in a marginal way. In this case, it is important to record the main
activity of the establishment or its sub-unit.
The deﬁnition in Council Directive 64/432/EEC was excluded as the list of products is too inclusive and, at the same time, the list of animals is too
restrictive for the purposes of SIGMA.
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16. MILK (under SUB-UNIT – PRODUCTION TYPE)
Agreed deﬁnition: Rearing or keeping in captivity animals for the primary purpose of producing raw milk, i.e. milk produced by the secretion of the
mammary gland of farmed animals that has not been heated to more than 40C or undergone any treatment that has an equivalent effect.
Def ID# LEGAL REFERENCE DEFINITION
Regulation (EC) No 853/2004, ANNEX I (4.1) ‘Raw milk’ means milk produced by the secretion of the mammary gland of farmed animals that
has not been heated to more than 40°C or undergone any treatment that has an equivalent effect
Regulation (EC) No 853/2004, ANNEX I (4.2) Milk production holding” means an establishment where one or more farmed animals are kept to
produce milk with a view to placing it on the market as food
EFSA decided to insert the term ‘primary purpose’ as there are cases where the establishment may put on the market other categories of products, but
in a marginal way. In this case, it is important to record the main activity of the establishment or its sub-unit.
17. EGGS (under SUB-UNIT – PRODUCTION TYPE)
Agreed deﬁnition: Rearing or keeping in captivity animals for the primary purpose of producing eggs, where ‘Eggs’ means eggs in shell — other than
broken, incubated or cooked eggs — that are produced by farmed birds and are ﬁt for direct human consumption or for the preparation of egg products
(also called ‘Table Eggs’).
Def ID# LEGAL REFERENCE DEFINITION
Regulation (EC) No 853/2004, ANNEX I (5.1) ‘Eggs’ means eggs in shell — other than broken, incubated or cooked eggs — that are produced
by farmed birds and are ﬁt for direct human consumption or for the preparation of egg products
Scientific Opinion on the public health risks of table eggs
due to deterioration and development of pathogens
EFSA decided to insert the term ‘primary purpose’ as there are cases where the establishment may put on the market other categories of products, but
in a marginal way. In this case, it is important to record the main activity of the establishment or its sub-unit. The term ‘Table Eggs’ was also introduced as
broadly used in the ﬁeld.
18. Speciﬁc Pathogen Free (SPF) (under SUB-UNIT – PRODUCTION TYPE)
Agreed deﬁnition: Animals or eggs which are used for diagnostic procedures in laboratories, for the production and testing of vaccines and for
research and pharmaceutical purposes.
Def ID# LEGAL REFERENCE DEFINITION
Commission Decision 2001/393/EC ‘Speciﬁed pathogen free (SPF)eggs are hatching eggs, which are used for diagnostic procedures in
laboratories, for the production and testing of vaccines and for research and pharmaceutical
purposes and have to be marked with a stamp
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19. FOIE GRAS (under SUB-UNIT – PRODUCTION TYPE)
Agreed deﬁnition: Rearing or keeping in captivity animals for the production of foie gras, where foie-gras means the livers of geese, or of ducks of the
species Cairina muschata or Cairina muschata x Anas platyrhynchos which have been fed in such a way as to produce hepatic fatty cellular hypertrophy.
Def ID# LEGAL REFERENCE DEFINITION
Commission Regulation (EC) No 543/2008, art. 1(3) The livers of geese, or of ducks of the species Cairina muschata or Cairina muschata x Anas
platyrhynchos which have been fed in such a way as to produce hepatic fatty cellular hypertrophy.
The birds from which such livers are removed shall have been completely bled, and the livers shall
be of a uniform colour.
The livers shall be of the following weight:
— duck livers shall weigh at least 300 g net,
— goose livers shall weigh at least 400 g net.
20. GAME (under SUB-UNIT – PRODUCTION TYPE)
Agreed deﬁnition: Animals kept in captivity for restocking supplies of game animals.
Def ID# LEGAL REFERENCE DEFINITION
Regulation (EC) No 853/2004, ANNEX I (1.6) “Farmed game” means farmed ratites and farmed land mammals other than those referred to in
point 1.2.(i.e. Domestic ungulates)
Regulation (EU) 2016/429 (AHL), art. 4(9) ‘poultry’ means birds that are reared or kept in captivity for:
[omitted]
(b) restocking supplies of game birds;
The deﬁnition in the Ϭ-ADM is the result of two deﬁnitions in the available legal acts listed. EFSA agreed to focus the attention to the scope of the
farming activity (restocking supplies) rather than on the animal species. It appeared obvious that a dairy farm or a dairy cow cannot fall under this category.
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21. CAPACITY (under SUB-UNIT)
Agreed deﬁnition: The capacity of the establishment, i.e. the number of animals approved by the authority that the establishment can host. For some
species it can be, as an example, number of cubicles or pen places.
Def ID# LEGAL REFERENCE DEFINITION
Regulation (EU) 2016/429 (AHL), art. 84(1) Operators of establishments keeping terrestrial animals or collecting, producing, processing or
storing germinal products shall, in order for their establishments to be registered in accordance
with Article 93, before they commence such activities:
[omitted]
(b) provide the competent authority with the following information:
[omitted]
(iii) the categories, species and numbers or quantities of kept terrestrial animals or germinal
products which they intend to keep on the establishment, and the capacity of the
establishment
It was decided to include this parameter as it could be, in some cases, one of the few harmonised parameter on the consistency of the production
activity. The Animal Health Law foresees the recording of this information. It has to be veriﬁed what is the level of implementation at EU level.
22. ACTUAL NUMBER (under SUB-UNIT)
Agreed deﬁnition: The number of animals that the operators of an establishment keep or breed or rear in the establishment at a speciﬁc point in time.
23. KEPT ANIMAL
Agreed deﬁnition: any terrestrial animal which is kept by humans and registered with a unique ID.
Def ID# LEGAL REFERENCE DEFINITION
Regulation (EU) 2016/429 (AHL), art. 4(2) ‘terrestrial animals’ means birds, terrestrial mammals, bees and bumble bees;
Regulation (EU) 2016/429 (AHL), art. 4(5) ‘kept animals’ means animals which are kept by humans, including, in the case of aquatic animals,
aquaculture animals;
At this point in time the species available among the enumeration values are limited to the ones relevant for the mandates received which are on ASF,
LSD, AI and EM. However, at any time EFSA shall assist on other diseases, the Ϭ-ADM will be readily integrated with the required values.
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Appendix D – Results of the systematic search in the Risk Assessment
Workﬂow (RAW)
Table D.1: Summary table of the question number and related mandate grouped by disease
Disease Mandate Output number Question number
AI M-2014-0316 ON-3941 EFSA-Q-2014-00838
M-2015-0079 EN-1142 EFSA-Q-2016-00792
EN-1282 EFSA-Q-2017-00573
EN-1283 EFSA-Q-2017-00574
EN-1284 EFSA-Q-2017-00575
EN-1285 EFSA-Q-2017-00576
EN-1286 EFSA-Q-2017-00577
EN-1287 EFSA-Q-2017-00578
ON-4687 EFSA-Q-2016-00777
ON-4991 EFSA-Q-2015-00214
EFSA-Q-2016-00348
M-2015-0240 ON-4891 EFSA-Q-2016-00599
M-2017-0062 ON-5018 EFSA-Q-2017-00229
ON-5141 EFSA-Q-2017-00649
ASF M-2014-0057 ON-3616 EFSA-Q-2014-00149
M-2014-0079 ON-4795 EFSA-Q-2017-00158
M-2014-0323 EN-843 EFSA-Q-2015-00401
ON-4163 EFSA-Q-2014-00897
M-2016-0048 EN-1312 EFSA-Q-2017-00155
ON-4732 EFSA-Q-2016-00152
ON-5068 EFSA-Q-2017-00154
EM M-2012-0200 EN-366 EFSA-Q-2012-00746
ON-2973 EFSA-Q-2012-00640
ON-3465 EFSA-Q-2013-00535
ON-3875 EFSA-Q-2013-00536
ON-4310 EFSA-Q-2013-00537
ON-4649 EFSA-Q-2014-00734
ON-5051 EFSA-Q-2017-00403
M-2014-0287 ON-4035 EFSA-Q-2014-00727
ON-5051 EFSA-Q-2017-00697
M-2014-0288 ON-4373 EFSA-Q-2014-00728
LSD M-2013-0332 ON-3986 EFSA-Q-2013-00917
M-2016-0122 ON-4573 EFSA-Q-2016-00384
M-2016-0170 ON-4773 EFSA-Q-2016-00542
ON-5176 EFSA-Q-2016-00625
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Table D.2: Detailed table of the question number and related mandate and output per disease
Disease Keywords Time span Mandate Question number Subject Output number
AI HPAI 1/1/2014–
31/12/2017
M-2015-0079 EFSA-Q-2017-00576 Procurement: Data analysis and predictive modelling of HPAI H5 and
H7 outbreaks in the EU 2005–2015
EN-1285
AI HPAI 1/1/2014–
31/12/2017
M-2015-0079 EFSA-Q-2017-00575 Procurement: Report about HPAI introduction into Europe, HPAI
detection in wild birds and HPAI spread between European holdings
in the period 2005–2015
EN-1284
AI HPAI 1/1/2014–
31/12/2017
M-2015-0079 EFSA-Q-2016-00792 Procurement: Effect of biosecurity measures and early detection
systems, mitigation measures and surveillance strategies on the
spread of HPAI and LPAI between farms
EN-1142
AI HPAI 1/1/2014–
31/12/2017
M-2015-0079 EFSA-Q-2016-00348 Art. 29: Scientiﬁc opinion on additional issues in relation to EFSA’s
ongoing mandate on avian inﬂuenza (M-2015-0079)
ON-4991
AI HPAI 1/1/2014–
31/12/2017
M-2015-0079 EFSA-Q-2015-00214 Art. 29: Scientiﬁc opinion on avian inﬂuenza (HPAI) ON-4991
AI LPAI 1/1/2014–
31/12/2017
M-2015-0079 EFSA-Q-2017-00577 Procurement: LPAI detection in wild birds and LPAI spread between
European holdings in the period 2005–2015
EN-1286
AI LPAI 1/1/2014–
31/12/2017
M-2015-0079 EFSA-Q-2016-00792 Procurement: Effect of biosecurity measures and early detection
systems, mitigation measures and surveillance strategies on the
spread of HPAI and LPAI between farms
EN-1142
AI Avian inﬂuenza 1/1/2014–
31/12/2017
M-2017-0221 EFSA-Q-2017-00829 Scientiﬁc and technical assistance on avian inﬂuenza surveillance -
Art 31.
AI Avian inﬂuenza 1/1/2014–
31/12/2017
M-2017-0062 EFSA-Q-2017-00825 Art. 31: Scientiﬁc and technical assistance on avian inﬂuenza
monitoring (Dec–Jan–Feb 2017/2018)
AI Avian inﬂuenza 1/1/2014–
31/12/2017
M-2017-0062 EFSA-Q-2017-00649 Art. 31: Scientiﬁc and technical assistance on avian inﬂuenza
monitoring (September–October–November 2017)
ON-5141
AI Avian inﬂuenza 1/1/2014–
31/12/2017
M-2015-0079 EFSA-Q-2017-00578 Procurement: Mechanisms and risk factors for mutation from low to
highly pathogenic avian inﬂuenza virus
EN-1287
AI Avian inﬂuenza 1/1/2014–
31/12/2017
M-2015-0079 EFSA-Q-2017-00574 Procurement: Narrative overview on wild bird migration in the
context of highly pathogenic avian inﬂuenza incursion into the
European Union
EN-1283
AI Avian inﬂuenza 1/1/2014–
31/12/2017
M-2015-0079 EFSA-Q-2017-00573 Risk factors of primary introduction of highly pathogenic and low
pathogenic avian inﬂuenza virus into European poultry holdings,
considering at least material contaminated by wild birds and contact
with wild birds
EN-1282
AI Avian inﬂuenza 1/1/2014–
31/12/2017
M-2017-0062 EFSA-Q-2017-00229 Art. 31: Scientiﬁc and technical assistance on avian inﬂuenza
monitoring (October 2016–August 2017)
ON-5018
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Disease Keywords Time span Mandate Question number Subject Output number
AI Avian inﬂuenza 1/1/2014–
31/12/2017
M-2015-0079 EFSA-Q-2016-00777 Urgent reply to and clariﬁcations of terms of reference (ToR)2 of the
avian inﬂuenza mandate
ON-4687
AI Avian inﬂuenza 1/1/2014–
31/12/2017
M-2015-0240 EFSA-Q-2016-00616 Procurement: Data collection on INFECTION WITH LOW
PATHOGENIC AVIAN INFLUENZA VIRUS
AI Avian inﬂuenza 1/1/2014–
31/12/2017
M-2015-0240 EFSA-Q-2016-00599 Art. 29: Scientiﬁc Opinion on INFECTION WITH LOW PATHOGENIC
AVIAN INFLUENZA VIRUS for the listing and categorisation of animal
diseases in the framework of the Animal Health Law
ON-4891
AI Avian inﬂuenza 1/1/2014–
31/12/2017
M-2015-0079 EFSA-Q-2016-00372 Workshop on Avian Inﬂuenza EN-1052
AI Avian inﬂuenza 1/1/2014–
31/12/2017
M-2015-0079 EFSA-Q-2016-00348 Art. 29: Scientiﬁc opinion on additional issues in relation to EFSA’s
ongoing mandate on avian inﬂuenza (M-2015-0079)
ON-4991
AI Avian inﬂuenza 1/1/2014–
31/12/2017
M-2015-0079 EFSA-Q-2015-00686 Procurement linked to scientiﬁc opinion on avian inﬂuenza: data
collection and spatial models for virus spread in preparation to the
mandate on avian inﬂuenza (OC/EFSA/ALPHA/2015/01)
AI Avian inﬂuenza 1/1/2014–
31/12/2017
M-2015-0079 EFSA-Q-2015-00214 Art. 29: Scientiﬁc opinion on avian inﬂuenza (HPAI) ON-4991
AI Avian inﬂuenza 1/1/2014–
31/12/2017
M-2014-0316 EFSA-Q-2014-00838 Scientiﬁc report on Highly pathogenic avian inﬂuenza A subtype
H5N8
ON-3941
ASF ASF 1/1/2014–
31/12/2017
M-2016-0048 EFSA-Q-2017-00155 Procurement: Simulation-based investigation of ASF spread and
control in wildlife without consideration of human non-compliance to
biosecurity (NP/EFSA/ALPHA/2017/11)
EN-1312
ASF ASF 1/1/2014–
31/12/2017
M-2014-0323 EFSA-Q-2015-00401 Procurement: Alternative control strategies against ASF in wild boar
populations (NP-EFSA-ALPHA-2015-15-ASF)
EN-843
ASF ASF 1/1/2014–
31/12/2017
M-2014-0323 EFSA-Q-2014-00897 Scientiﬁc opinion on African swine fever (ASF) ON-4163
ASF African Swine
Fever
1/1/2014–
31/12/2017
M-2017-0217 EFSA-Q-2018-00053 Art. 31: Scientiﬁc and technical assistance on African swine fever
ASF African Swine
Fever
1/1/2014–
31/12/2017
M-2017-0217 EFSA-Q-2017-00823 Art. 31: Scientiﬁc and technical assistance on African swine fever
ASF African Swine
Fever
1/1/2014–
31/12/2017
M-2016-0048 EFSA-Q-2017-00725 Event report for African Swine Fever workshop EN-1342
ASF African Swine
Fever
1/1/2014–
31/12/2017
M-2014-0079 EFSA-Q-2017-00158 Characterisation of African swine fever virus for scientiﬁc opinion on
vector-borne diseases
ON-4795
ASF African Swine
Fever
1/1/2014–
31/12/2017
M-2016-0048 EFSA-Q-2017-00154 Art. 31 Technical and scientiﬁc assistance on African swine fever
(2017)
ON-5068
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Disease Keywords Time span Mandate Question number Subject Output number
ASF African Swine
Fever
1/1/2014–
31/12/2017
M-2016-0048 EFSA-Q-2016-00152 Art. 31 Technical and scientiﬁc assistance on African swine fever
(2016)
ON-4732
ASF African Swine
Fever
1/1/2014–
31/12/2017
M-2014-0323 EFSA-Q-2014-00897 Scientiﬁc opinion on African swine fever (ASF) ON-4163
ASF African Swine
Fever
1/1/2014–
31/12/2017
M-2014-0057 EFSA-Q-2014-00149 Request for urgent scientiﬁc and technical assistance on the
evaluation of hunting wild boar as a mitigation measure to prevent
the introduction of African swine fever from area infected by the
disease.
ON-3616
LSD LSD 1/1/2014–
31/12/2017
M-2014-0330 EFSA-Q-2016-00412 Workshop on strengthening regional cooperation in South East
Europe and Middle East for prevention and control of Lumpy Skin
Disease (LSD)
EN-1059
LSD Lumpy skin
disease
1/1/2014–
31/12/2017
M-2016-0170 EFSA-Q-2016-00625 Art. 31 Scientiﬁc and technical assistance on Lumpy Skin Disease
(report 2018)
ON-5176
LSD Lumpy skin
disease
1/1/2014–
31/12/2017
M-2016-0170 EFSA-Q-2016-00542 Art. 31 Scientiﬁc and technical assistance on Lumpy Skin Disease
(report 2017)
ON-4773
LSD Lumpy skin
disease
1/1/2014–
31/12/2017
M-2014-0330 EFSA-Q-2016-00412 Workshop on strengthening regional cooperation in South East
Europe and Middle East for prevention and control of Lumpy Skin
Disease (LSD)
EN-1059
LSD Lumpy skin
disease
1/1/2014 -
31/12/2017
M-2016-0122 EFSA-Q-2016-00384 Art. 29: Urgent advice on the update of the scientiﬁc opinion on
lumpy skin disease
ON-4573
LSD Lumpy Skin
Disease
1/1/2014–
31/12/2017
M-2013-0332 EFSA-Q-2013-00917 Scientiﬁc opinion on lumpy skin disease ON-3986
EM Echinococcus 1/1/2012–
31/12/2017
M-2014-0287 EFSA-Q-2017-00697 Art. 31: Scientiﬁc and technical assistance on Echinococcus
multilocularis infection in animals(2017)
ON-5051
EM Echinococcus 1/1/2012–
31/12/2017
M-2012-0200 EFSA-Q-2017-00403 Art. 31: Scientiﬁc and technical assistance on Echinococcus
multilocularis infection in animals(2017)
ON-5051
EM Echinococcus 1/1/2012–
31/12/2017
M-2012-0200 EFSA-Q-2014-00734 Art. 31: Scientiﬁc and technical assistance on Echinococcus
multilocularis infection in animals(2016)
ON-4649
EM Echinococcus 1/1/2012–
31/12/2017
M-2014-0288 EFSA-Q-2014-00728 Scientiﬁc opinion Echinococcus multilocularis infection in animals ON-4373
EM Echinococcus 1/1/2012–
31/12/2017
M-2014-0287 EFSA-Q-2014-00727 Scientiﬁc and technical assistance concerning the 2013 Report on
Surveillance of Echinococcus Multilocularis in Norway
ON-4035
EM Echinococcus 1/1/2012–
31/12/2017
M-2012-0200 EFSA-Q-2013-00537 Art. 31: Scientiﬁc and technical assistance on Echinococcus
multilocularis infection in animals (2015)
ON-4310
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Disease Keywords Time span Mandate Question number Subject Output number
EM Echinococcus 1/1/2012–
31/12/2017
M-2012-0200 EFSA-Q-2013-00536 Scientiﬁc and technical assistance on Echinococcus multilocularis
infection in animals (2014)
ON-3875
EM Echinococcus 1/1/2012–
31/12/2017
M-2012-0200 EFSA-Q-2013-00535 Scientiﬁc and technical assistance on Echinococcus multilocularis
infection in animals (2013)
ON-3465
EM Echinococcus 1/1/2012–
31/12/2017
M-2012-0200 EFSA-Q-2012-00640 Request for scientiﬁc and technical assistance on Echinococcus
multilocularis infection in animals
ON-2973
EM Echinococcus 1/1/2012–
31/12/2017
M-2012-0200 EFSA-Q-2012-00746 Request for scientiﬁc and technical assistance on Echinococcus
multilocularis infection in animals
EN-366
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Appendix E – List of terms of reference and related epidemiological question category
Mandate
number
Terms of reference Epidemiological question category
M-2014-0316 Epidemiological analysis of the current situation regarding HPAI subtype H5N8 in Europe in order to assess
possible entry routes and in particular the role played by wild birds
Descriptive statistics
M-2014-0316 Epidemiological analysis of the current situation regarding HPAI subtype H5N8 in Europe in order to assess
possible entry routes and in particular the role played by wild birds
Risk factors analysis
M-2014-0316 Review of the epidemiological situation of HP AI subtype H5N8 in the world Descriptive statistics
M-2015-0079 Risk of introduction of HPAI H5N8 and possibly other HPAI viruses considering the possible entry routes in EU Probability of introduction
M-2015-0079 The risk posed by HPAI H5N8 and possibly other HPAI viruses for public and animal health, and speciﬁcally with a
view to assess the suitability of the provisions on BIOSECURITY and early detection to reduce the risk of its
introduction into poultry holdings laid down in Decision 2005/734/EC
Effectiveness of biosecurity measures
M-2015-0079 The risk posed by HPAI H5N8 and possibly other HPAI viruses for public and animal health, and speciﬁcally with a
view to assess the suitability of the provisions on biosecurity and EARLY DETECTION to reduce the risk of its
introduction into poultry holdings laid down in Decision 2005/734/EC
Effectiveness of sampling schemes
M-2015-0079 The risk posed by HPAI H5N8 and possibly other HPAI viruses for public and animal health, and speciﬁcally with a
view to assess the suitability of the provisions on PROTECTION MEASURES in poultry in case of its
occurrence in wild birds laid down in Decision 2006/563/EC
Effectiveness of protection measures
M-2015-0079 The risk posed by HPAI H5N8 and possibly other HPAI viruses for public and animal health, and speciﬁcally with a
view to assess the suitability of the provisions on THE SURVEILLANCE STRATEGY, in particular objectives
and methodology, laid down in Decision 2010/367/EC
Effectiveness of sampling schemes
M-2015-0079 The current situation in EU and elsewhere as regards the risk of possible introduction of HPAI H5N8 virus and
possibly other HPAI viruses to EU poultry holdings
Descriptive statistics
M-2015-0079 The continuous risk posed by LPAI (H5 & H7) for the introduction from the wild bird reservoir into poultry
holdings taking into account risks for holdings where poultry is kept in open air runs [. . .]
Probability of introduction
M-2015-0079 The continuous risk posed by LPAI (H5 & H7) for the introduction from the wild bird reservoir into poultry
holdings taking into account risks for holdings where poultry is kept in open air runs [. . .]
Risk factors analysis
M-2015-0079 [. . .] and the suitability of SURVEILLANCE [. . .] Effectiveness of sampling schemes
M-2015-0079 [. . .] and BIOSECURITY MEASURES aimed at protection of poultry against LPAI infection Effectiveness of biosecurity measures
M-2014-0057 Is it feasible to drastically reduce the wild boar population by hunting or by the use of traps? In case of positive
reply, for how long that strategy would need to be put in place in order to prevent a new increase of the density
of the population?
Trend analysis
M-2014-0057 Could increased hunting pressure be a proper disease management tool in disease free areas adjacent to area(s)
where the occurrence of virus has been conﬁrmed in the wild boar, to minimise the risk of ASF introduction?
Effectiveness of protection measures
M-2014-0057 Would hunting signiﬁcantly reduce the risk of ASF introduction and its spread? Effectiveness of countermeasures
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Mandate
number
Terms of reference Epidemiological question category
M-2014-0057 Would prevention of movement of wild boars by feeding or artiﬁcial physical barriers reduce the risk of spread of
ASF?
Effectiveness of countermeasures
M-2014-0323 In view of controlling ASF, assess the best management options for wild boar both in infected areas and in the
bordering risk areas, taking into account the local climatic conditions and wild boar ecology. Assess in particular
the suitability, effectiveness and the practical aspects of implementation of the main measures, in particular
different tailor-made feed ban(s) for wild boar, selective well-described hunting practices, taking into account the
local situations and giving quantitative baseline indications on these measures as well as spatial and temporal
parameters.
Risk factors analysis
M-2014-0323 In view of controlling ASF, assess the best management options for wild boar both in infected areas and in the
bordering risk areas, taking into account the local climatic conditions and wild boar ecology. Assess in particular
the suitability, effectiveness and the practical aspects of implementation of the main measures, in
particular different tailor-made feed ban(s) for wild boar, selective well-described hunting practices, taking into
account the local situations and giving quantitative baseline indications on these measures as well as spatial and
temporal parameters
Effectiveness of countermeasures
M-2014-0323 Evaluate the epidemiological data on ASF from Lithuania, Poland, Latvia and Estonia in order to obtain
indications on the local behaviour of ASF in the wild boar population and its interaction with domestic pigs
Descriptive statistics
M-2014-0323 Assess the possible risk of spread of ASF-Genotype II strains/isolates currently or recently circulating in Europe,
and especially in Russia or the Baltic States, by pigs or wild boar becoming “carrier” that might play a role in virus
transmission while remaining non-symptomatic
Spread pattern analysis
M-2014-0323 Where new data is available, provide an update of previous Scientiﬁc Opinions on ASF, in particular: i) describe
identiﬁable relevant trends in wild boar population dynamics in the EU and its Eastern neighbouring
territories; and ii) provide an updated distribution of ASF competent vectors (soft ticks) and its possible role on
ASF epidemiology specially in Russia or the Baltic States
Trend analysis
M-2014-0323 Where new data is available, provide an update of previous Scientiﬁc Opinions on ASF, in particular: i) describe
identiﬁable relevant trends in wild boar population dynamics in the EU and its Eastern neighbouring territories;
and ii) provide an updated distribution of ASF competent vectors (soft ticks) and its possible role on
ASF epidemiology specially in Russia or the Baltic States
Descriptive statistics
M-2016-0048 Analyse the epidemiological data on ASF in Estonia, Latvia, Lithuania, Poland and any other Member States at the
eastern borders of the EU that might be affected by ASF
Descriptive statistics
M-2016-0048 Include an analysis of the TEMPORAL pattern of ASF in wild boar and domestic pigs Trend analysis
M-2016-0048 Include an analysis of the SPATIAL pattern of ASF in wild boar and domestic pigs Trend analysis
M-2016-0048 Include an analysis of the RISK FACTORS involved in the occurrence, spread and persistence of the ASF virus in
the wild boar population and in the domestic wildlife interface
Risk factors analysis
M-2013-0332 Characterise the disease and provide an update on the global occurrence of LSD and changes in the
distribution during the last 10 years
Descriptive statistics
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Mandate
number
Terms of reference Epidemiological question category
M-2013-0332 Characterise the disease and provide an update on the global occurrence of LSD and changes in the
distribution during the last 10 years
Trend analysis
M-2013-0332 Provide a mapping of the region of concern and other countries of the Mediterranean Basin and Black Sea,
displaying identiﬁed, or likely, major live animal trade routes
Descriptive statistics
M-2013-0332 Evaluate all possible pathways of introduction of LSD into the EU, ranking them on the basis of their level of risk,
with a view to enhance preparedness and prevention
Risk factors analysis
M-2013-0332 Assess the risk and speed of propagation of LSD into the EU and neighbouring countries Spread pattern analysis
M-2013-0332 Assess the risk of LSD becoming endemic in animal population in the EU and neighboring countries Probability of endemicity
M-2013-0332 Assess the impact of LSD if it were to enter the EU considering different scenarios as regards the effectiveness of
surveillance and control measures
Impact assessment
M-2013-0332 Brieﬂy review the feasibility, availability, and effectiveness of the main disease prevention and control measures
(diagnostic tools, biosecurity measures, restrictions on the movements, culling)
Effectiveness of sampling schemes
M-2013-0332 Brieﬂy review the feasibility, availability, and effectiveness of the main disease prevention and control measures
(diagnostic tools, biosecurity measures, restrictions on the movements, culling)
Effectiveness of biosecurity measures
M-2013-0332 Brieﬂy review the feasibility, availability, and effectiveness of the main disease prevention and control measures
(diagnostic tools, biosecurity measures, restrictions on the movements, culling)
Effectiveness of countermeasures
M-2016-0122 Assess the implications in disease spread and persistence from the implementation of a partial stamping-
out policy (killing and destruction of clinically affected animals only) in holdings where the presence of LSD has
been conﬁrmed, against the current EFSA’s advice and policy in place for total stamping-out of infected herds
coupled with vaccination
Effectiveness of countermeasures
M-2016-0170 Analyse the epidemiological data on LSD from Cyprus, Greece, Bulgaria and any other Member States or non-EU
countries that might be affected by LSD
Descriptive statistics
M-2016-0170 Include an analysis of the temporal and spatial patterns of LSD Trend analysis
M-2016-0170 Include an analysis of the risk factors involved in the occurrence, spread and persistence of the LSD virus among
the cattle population
Risk factors analysis
M-2012-0200 Regular follow-up of the literature regarding EM infection in animals in the European Union and adjacent
countries, including its geographical distribution and prevalence;
Descriptive statistics
M-2012-0200 Analysis and critical assessment, in the context of Regulation (EU) No 1152/2011, of (i) the sampling strategy
considered for the programmes of the Member States concerned; (ii) the data collected in the framework
of these programmes; (iii) the detection methods used
Effectiveness of sampling schemes
M-2012-0200 Analysis and critical assessment, in the context of Regulation (EU) No 1152/2011, of (i) the sampling strategy
considered for the programmes of the Member States concerned; (ii) the data collected in the framework of
these programmes; (iii) the detection methods used
Descriptive statistics
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Mandate
number
Terms of reference Epidemiological question category
M-2012-0200 Analysis and critical assessment, in the context of Regulation (EU) No 1152/2011, of (i) the sampling strategy
considered for the programmes of the Member States concerned; (ii) the data collected in the framework of these
programmes; (iii) the detection methods used
Effectiveness of sampling schemes
M-2014-0288 1. To describe Echinococcus multilocularis infection in animals in the European Union and adjacent countries and
in particular:
a) the geographical distribution and prevalence of Echinococcus multilocularis infection in the main
infected domestic and wildlife species involved in the Echinococcus multilocularis lifecycle; b) the
importance and role of the different host species in the life cycle of the parasite; c) the risk factors for and the
probability of introduction and establishment of Echinococcus multilocularis in areas where it has never been
recorded, through the movement of infected domestic and wildlife species involved in the Echinococcus
multilocularis lifecycle;
Descriptive statistics
M-2014-0288 1. To describe Echinococcus multilocularis infection in animals in the European Union and adjacent countries and
in particular:
a) the geographical distribution and prevalence of Echinococcus multilocularis infection in the main infected
domestic and wildlife species involved in the Echinococcus multilocularis lifecycle; b) the importance and role
of the different host species in the life cycle of the parasite; c) the risk factors for and the probability of
introduction and establishment of Echinococcus multilocularis in areas where it has never been recorded, through
the movement of infected domestic and wildlife species involved in the Echinococcus multilocularis lifecycle;
Risk factors analysis
M-2014-0288 1. To describe Echinococcus multilocularis infection in animals in the European Union and adjacent countries and
in particular:
a) the geographical distribution and prevalence of Echinococcus multilocularis infection in the main infected
domestic and wildlife species involved in the Echinococcus multilocularis lifecycle; b) the importance and role of
the different host species in the life cycle of the parasite; c) the risk factors for and the probability of
introduction and establishment of Echinococcus multilocularis in areas where it has never been recorded,
through the movement of infected domestic and wildlife species involved in the Echinococcus multilocularis
lifecycle;
Risk factors analysis
M-2014-0288 1. To describe Echinococcus multilocularis infection in animals in the European Union and adjacent countries and
in particular:
a) the geographical distribution and prevalence of Echinococcus multilocularis infection in the main infected
domestic and wildlife species involved in the Echinococcus multilocularis lifecycle; b) the importance and role of
the different host species in the life cycle of the parasite; c) the risk factors for and the probability of
introduction and establishment of Echinococcus multilocularis in areas where it has never been recorded,
through the movement of infected domestic and wildlife species involved in the Echinococcus multilocularis
lifecycle;
Probability of introduction
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Mandate
number
Terms of reference Epidemiological question category
M-2014-0288 2. To assess the current situation in the European Union and adjacent countries regarding:
a) the monitoring and surveillance programmes of Echinococcus multilocularis infection in deﬁnitive
and intermediate hosts, and the probability of detection if Echinococcus multilocularis is introduced into areas
where it is has never been recorded; b) the programmes for the eradication of Echinococcus multilocularis in
wildlife host species;
Effectiveness of sampling schemes
M-2014-0288 2. To assess the current situation in the European Union and adjacent countries regarding:
a) the monitoring and surveillance programmes of Echinococcus multilocularis infection in deﬁnitive and
intermediate hosts, and the probability of detection if Echinococcus multilocularis is introduced into
areas where it is has never been recorded; b) the programmes for the eradication of Echinococcus
multilocularis in wildlife host species;
Effectiveness of sampling schemes
M-2014-0288 2. To assess the current situation in the European Union and adjacent countries regarding:
a) the monitoring and surveillance programmes of Echinococcus multilocularis infection in deﬁnitive and
intermediate hosts, and the probability of detection if Echinococcus multilocularis is introduced into areas where it
is has never been recorded; b) the programmes for the eradication of Echinococcus multilocularis in
wildlife host species;
Effectiveness of countermeasures
M-2014-0288 3. To describe the current situation in the European Union and adjacent countries regarding:
a) the risk factors associated with human alveolar echinococcosis; b) the impact of Echinococcus
multilocularis infection in animals on public health;
Risk factors analysis
M-2014-0288 3. To describe the current situation in the European Union and adjacent countries regarding: a) the risk factors
associated with human alveolar echinococcosis; b) the impact of Echinococcus multilocularis infection in
animals on public health;
Impact assessment
M-2014-0288 4. To describe the efﬁcacy of available Echinococcus multilocularis drugs and the effectiveness of the current
species-speciﬁc treatment protocols to protect domestic species against the parasite;
Effectiveness of countermeasures
M-2014-0288 5. To assess the laboratory techniques for the detection of Echinococcus multilocularis in live and dead animals, in
terms of sensitivity, speciﬁcity, predictive values and practicability (i.e. rapidity, large scale use, ease of use)
Effectiveness of sampling schemes
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Appendix F – List and deﬁnitions of possible statistical analysis and approaches and/or parameters as per the
Preliminary Plan of Analysis
Analysis and approaches
Number of times
required
Deﬁnition
(Incidence) rate 1 Ratio in which the denominator is the number of animal-time units at risk*
Also, a ratio in which the denominator is time. E.g. cases/day, cases/week, etc.
Attack rates 2 It is the risk of becoming infected (case) during a speciﬁc period of time, such as the duration of an outbreak. It is
calculated by dividing the total number of new cases by the total number of individuals at risk (total population
exposed)
Attributable fraction 1 Proportion of disease in exposed individuals that is due to the exposure OR proportion of disease in the exposed
group that would be avoided if the exposure were removed*
Attributable risk 1 Risk of disease in the exposed group MINUS the risk of disease in the non-exposed group (i.e. increased or
decreased probability of disease in the exposed group*
Case fatality rate 1 Proportion of animals with a speciﬁc disease that die from it (within a speciﬁc time period)
It’s a risk measure. Used to describe the impact
Count 1 Simple enumeration of the number of cases of disease or number of animals affected with a condition in a given
population.
Descriptive risk mapping 1 For aggregated data. Crude risk or risk ratios can be calculated and reported in maps.
Distribution maps 1 Simple geographical representation of a given parameter (e.g. prevalence) or event (e.g. disease notiﬁcation)*
Freedom from disease 2 It is an approach based on the Binomial distribution, used in areas where the disease or a pathogen is not
circulating, for different purposes, e.g. estimation of the conﬁdence on the free status of a given disease, the
calculation of the required sample size to demonstrate freedom, etc
Hazard ratio 2 In survival analysis, the hazard ratio is the ratio of the hazard rates corresponding to the conditions described by two
levels of an explanatory variable. Hazard ratios have similar interpretations to odds ratios and risk ratios*
Incidence count 1 Enumeration of new cases in a population during certain time*
Incidence rate 2 Number of new cases of disease in a population per unit of animal-time during a given time period.
Eg. No. cases/No. animal-days*
Incidence rate ratio/
Incidence density
1 Ratio of the disease frequency (measured as incidence rate) in an exposed group to the Incidence Rate in a
non-expose group*
Incidence risk/Cumulative
incidence
1 Probability that an individual animal will contract or develop a disease in a deﬁned time period. Also referred to as
‘cumulative incidence’*
Incidence times 1 Times at which incident cases occur. Usually measured as the elapsed time since a reference event (e.g. calving)*
Modelling techniques 8 The adaptation of a parametric model to empirical distributions in order to estimate the parameters and operate
probabilistic calculations
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Analysis and approaches
Number of times
required
Deﬁnition
Odds 1 Ratio in which the numerator is not a subset of the denominator. It can be interpreted as the likelihood that a case
would take place. This is the ratio of cases to non-cases or p/(1  p)*
Odds ratio 4 Odds of the disease in the exposed group divided by the disease odds in the non-expose group*
Population attributable
fraction
1 Analogous to Attributable Fraction BUT reﬂects the effect of the disease in the entire population (rather than in the
exposed group)*
Population attributable risk 1 Difference in risk between two groups BUT focus on increase in risk of disease, in the entire population, attributable
to the exposure*
Prevalence 1 Proportion or percentage of cases in the population at a speciﬁc point in time. Eg. cases/population*
Proportion 1 Ratio in which the numerator is a subset of the denominator*
R0 (Basic reproductive
ratio)
1 Average number of secondary cases produced by one infectious individual in completely susceptible population
Regression techniques 1 E.g. Generalised linear models
Relative risk/risk ratio 4 Ratio of the risk of disease in the exposed group to the risk of disease in the non-expose group. Also referred to as
‘Risk Ratio’*
Secondary attack rates 2 Number of cases MINUS the initial case(s)*
It describes the “infectiousness” (or ease of spread) of living agents
Simulation techniques 8 The implementation of virtual (computer) sampling from a parametric or empirical distribution in order to estimate
the parameter of interest (a probability or a quantity) and its uncertainty/variability e.g. SIR models. These
techniques are normally used for predictive purposes
Smoothing (kernel)
methods
1 Techniques used in spatial analysis which convert large sets of points into a density surface
Transmission kernel 1 The transmission kernel describes the risk of transmission as a function of distance between an infectious and a
susceptible holding
Transmission rate 1 The number of new cases produced by one infectious individual per unit of time
*: Dohoo, Martin, Stryhn; 2010. Veterinary epidemiological Research – 2nd edition.
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Appendix G – List and deﬁnitions of the identiﬁed categories of data input
Input data category
Number of times
required
Deﬁnition
Case 10 An individual animal infected by a pathogenic agent, with or without clinical signs. (OIE terrestrial code)
Time 8 It’s the point in time (usually a date) linked to a speciﬁc event or on which a given information is recorded
Population 4 As a very broad deﬁnition, the population can be described as any group of units sharing a common deﬁned characteristic
(OIE). From a statistical point of view, this can be either the target population (i.e. the population to which it might be
possible to extrapolate results from a study) or the source population (i.e. the population from which the study subjects are
drawn). It is at source population level that a risk assessor is asked to infer
Population size 6 Total number of units in a population
Population
composition
5 Description of the population according to deﬁned characteristics e.g. Sex, age, production type
Exposure 5 Epidemiological term applied to any factor (risk factor) that may be associated with an outcome of interest. If the outcome
of interest is occurrence of disease, then exposure is any characteristic (e.g. existence of infected animals, vaccination
status, etc.) that may affect the health outcome (diseased/not-diseased)
In relation to a given risk factor, an individual animal has come into contact with, or is predisposed to becoming infected
with a pathogen which would result in an increased likelihood of becoming infected
Geographical
Location
3 The most detailed information on the positioning of an entity on Earth
Test diagnostic
sensitivity
2 The diagnostic sensitivity of the analytical test (according to the OIE Manual)
Test diagnostic
speciﬁcity
2 The diagnostic speciﬁcity of the analytical test (according to the OIE Manual)
Animal movements 1 The list of all movements of an animal since its birth until its death, with details on the establishments in which it is kept
Sampling scheme 1 The underpinning rationale/statistical approach used to perform all relevant steps in a sampling exercise, i.e. deﬁnition of
the goal, estimation of the sample size, selection of the sampling units, etc.
Species/Breed 1 Genus, species and, when relevant, breed of the concerned animals
Vaccination status 1 The status of the animal in relation to the vaccine intervention
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Appendix H – A Zoonoses perspective: the case of double reporting of
animal populations
Introduction
H.1. Issue
For more than 10 years, the European Food Safety Authority (EFSA) has been tasked with the
European Union (EU)-wide data collection on zoonoses, zoonotic agents, antimicrobial resistance and
food-borne outbreaks. Annually EFSA produces, jointly with the European Centre for Disease Prevention
and Control, EU Summary Reports that integrate all information along the food chain. Member States
(MSs) have a legal obligation to monitor trends and sources of zoonoses, zoonotic agents and
antimicrobial resistance and food-borne outbreaks and to transmit the results of monitoring
programmes to the European Commission, which should be subsequently be forwarded to
EFSA. In 2004, the European Commission entrusted EFSA with the task of setting up an electronic
reporting system and a database concerning monitoring of zoonoses (EFSA mandate No 2004-017810).
Thus, in practice, data are sent directly from the MS data providers to EFSA (Gilsenan MB,
201511). A short review summarising the achievements made with this integrated food-chain data
collection and information system, identifying lessons learnt and describing challenges for improving the
quality and the use of the collected data on food, animals and feed can be found elsewhere.12
Table H.1: Comparison between animal zoonoses data provided to EFSA and to the European
Commission
EFSA European Commission
Tasks and
purpose
• Focus on eight mandatory zoonoses
• Trends and sources : analyse and report
patterns over time
• Annual situational update
• Epidemiological data analysis
• Animal disease information
• Broader list of diseases to be reported in
comparison to EFSA
• Notiﬁcation
• Epidemiological data and ﬁnancial data
(reimbursement)
Data
collected
Food animal data, i.e.:
• Farm animals (poultry, ruminants, pigs,
solipeds), wildlife animals
• Animal- and herd- and holding-level data
variables
• Epidemiological data
Information on data models is in following of
the annual zoonoses monitoring data
reporting on zoonoses, food-borne outbreaks
and antimicrobial resistance (https://efsa.
onlinelibrary.wiley.com/doi/epdf/10.2903/
sp.efsa.2018.EN-1368)
Food animal data, i.e.:
• Mostly farm animals (poultry, ruminants,
pigs, solipeds)
• Animal- and herd- and holding-level data
variables
• Decision 2003/886/EC lists the data that the
European Commission requests from MS for
the Annual Report on bovine and swine
diseases as requested by Article 8 of
Directive 64/432/EEC
Financial data (Commission Decision 2014/
288/EU):
• D4
• Food safety programme
• emergency funding
Epidemiological data:
• G2
• Animal health and welfare, 2003/886/EC
10 EFSA Register of Questions: (entre the mandate number from this page).
11 Gilsenan M, 2015. Data handling: observatories/databases/data/storage/legal framework EFSA data collection. Options
Mediterraneennes, A111, 75–82.
12 Boelaert F, Amore G, Van der Stede Y, Hugas M, 2016. EU-wide monitoring of biological hazards along the food chain:
achievements, challenges and EFSA vision for the future. Current Opinion in Food Science, 12, 52–62.
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It is in this context of its general zoonoses mandate that EFSA collects MS-speciﬁc data on
animal populations. However, certain of these animal population data are also collected from
MS by the European Commission (DG Sante: G2 unit ‘Animal health and welfare’ and D4 unit
‘Food safety programme, emergency funding’), in the context of MS’ control and eradication
programmes that are co-ﬁnanced by the European Commission.
These data are alike, although not always identical because of the different perspective
they are collected for, and the compulsory requirement for MS to report these to EFSA and to the
European Commission is underpinned by EU legislation. This issue is called ‘double reporting’.
It has been estimated that, on average, the effort required by a MS to collect and to submit to
EFSA the relevant animal population data and manage them to ﬁt the requirement of EFSA is of one
person for one week. The collection, validation and submission of the complete zoonoses datasets
require several months resources for one person (two to three).
H.2. Legislation
H.2.1. Animal population data submitted by MS to EFSA
Several pieces of legislation prescribe animal population data that MS ought to submit to EFSA. The
animal population data are submitted by MS to EFSA using the Data Collection Framework (DCF) using
XML or Excel or CSV formats. Animal population data can be submitted at level of animal species (e.g.
Gallus gallus) or subcategories/subpopulations (e.g. broilers).
• ‘Susceptible animal population data’
According to the Zoonoses Directive 2003/99/EC13, EFSA is responsible for examining the data on
zoonoses, antimicrobial resistance and food-borne outbreaks collected from the MSs and for preparing
the EU Summary Report (EUSR) (on trends of zoonoses and sources of zoonoses/food-borne
outbreaks) from the results.
These data, submitted to EFSA using the Animal population data model, include, as mentioned in
the Appendix IV, Figure H1
— number of herds or ﬂocks,
— total number of animals, and
— where relevant, methods of production involved,
and also the date these data (ﬁgures) relate to.
• Animal population data in the context of Salmonella National Control Programmes in
poultry
According to EU Regulation (EC) No 2160/200314, MS have to set up Salmonella National Control
Programmes (NCP) aimed at reducing the prevalence of Salmonella serovars, which are considered
relevant for public health, in certain animal populations. Currently, prevalence targets have been deﬁned
for breeding ﬂocks of Gallus gallus (Regulation (EC) No 200/201015), laying hens (Regulation (EU) No
517/201116), broilers (Regulation (EC) No 200/201217) and breeding and fattening turkeys (Regulation
(EU) No 1190/201218). The National Contact Points (NCP) are set up in individual MS to achieve the EU
13 Directive 2003/99/EC of the European Parliament and of the Council of 17 November 2003 on the monitoring of zoonoses and
zoonotic agents, amending Council Decision 90/424/EEC and repealing Council Directive 92/117/EEC. OJ L 325, 12.12.2003,
p. 31–40.
14 Regulation (EC) No 2160/2003 of the European Parliament and of the Council and Regulation of 17 November 2003 on the
control of Salmonella and other speciﬁed food-borne zoonotic agents. OJ L 325, 12.12.2003, p. 1–15.
15 Commission Regulation (EU) No 200/2010 of 10 March 2010 implementing Regulation (EC) No 2160/2003 of the European
Parliament and of the Council as regards a Union target for the reduction of the prevalence of Salmonella serotypes in adult
breeding ﬂocks of Gallus gallus. OJ L 61, 11.3.2010, p. 1–9.
16 Commission Regulation (EU) No. 517/2011 of 25 May 2011 implementing Regulation (EC) No 2160/2003 of the European
Parliament and of the Council as regards a Union target for the reduction of the prevalence of certain Salmonella serotypes in
laying hens of Gallus gallus and amending Regulation (EC) No. 2160/2003 and Commission Regulation (EU) No 200/2010. OJ
L 138, 26.5.2011, p. 45–51.
17 Commission Regulation (EC) No. 200/2012 of 8 March 2012 on a Union target for the reduction of Salmonella Enteritidis and
Salmonella Typhimurium in ﬂocks of broilers, as provided for in Regulation (EC) No. 2160/2003 of the European Parliament
and of the Council. OJ L 71, 9.3.2012, p. 31–36.
18 Commission Regulation (EU) No. 1190/2012 of 12 December 2012 on a Union target for the reduction of Salmonella
Enteritidis and Salmonella Typhimurium in ﬂocks of turkeys, as provided for in Regulation (EC) No. 2160/2003 of the European
Parliament and of the Council. OJ L 340, 13.12.2012, p. 29–34.
SIGMA Animal Disease Data Model: a comprehensive approach
www.efsa.europa.eu/efsajournal 57 EFSA Journal 2019;17(1):5556
prevalence targets in these animal populations at the primary production level. NCP have to be approved
by the European Commission, which evaluates the compliance of the programmes with the relevant EU
legislation. The results of the programmes have to be reported to the European Commission for
reimbursement and to EFSA as part of the annual EU zoonoses monitoring.
These data submitted to EFSA using the Prevalence data model, include;
 Total number of adult ﬂocks under the NCPs Total number of adult ﬂocks checked (tested).
• Animal population data in the context of National Control and Eradication Programmes
for bovine tuberculosis in cattle and in brucellosis in cattle and sheep and goats
Other Community legislation provides for the monitoring and control of certain zoonoses in animal
populations. In particular, Council Directive 64/432/EEC of 26 June 1964 on animal health problems
affecting intra-community trade in bovine animals and swine deals with bovine tuberculosis and bovine
brucellosis. Council Directive 91/68/EEC of 28 January 1991 on animal health conditions governing
intra-Community trade in ovine and caprine animals deals with ovine and caprine brucellosis. Since
directive 2003/99/EC may not create any unnecessary duplication of existing reporting requirements,
the EFSA zoonoses reporting system integrated the reporting tables speciﬁed in the two
aforementioned directives (64/432/EEC and 91/68/EEC). These data, submitted to EFSA using the
Disease Status data model, include;
 Number of existing herds/animals Number of herds/animals under the control programme Number of herds/animals checked (tested).
H.2.2. Animal population data provided to the European Commission
According to Regulation (EU) No 652/201419, grants may be awarded to MSs’ annual or
multiannual national programmes for the eradication, control and surveillance of a list of animal
diseases and zoonoses (listed in Annex II of Regulation (EU) No 652/2014). These or called ‘EC co-
ﬁnanced’ programmes. More information on National Veterinary Programmes, in EU can be found at
https://ec.europa.eu/food/funding/animal-health/national-veterinary-programmes_en
After execution MSs submit – for their co-ﬁnanced programmes – reports to the European
Commission on the obtained results and these reports serve also the purpose of underpinning their
request for reimbursement. Those reports are also published on the mentioned website.
What the European Commission requests the MS to provide are the measures performed during an
implementing year (from 1/1 to 31/12) for which MSs incurred a cost (i.e. the state budget paid totally
or partially the cost of the measure); this cost should have been paid by the time the MS send their
reimbursement claim, i.e. by 30/4 of the next year at the latest. For sampling (if the eligible
co-ﬁnanced measure is the act of taking samples), the samples shall have been taken between 1/1
and 31/12 and the MS shall have paid its ﬁnancial part before they send their reimbursement claim to
the European Commission. It results that animal population data sent by MS to the European
Commission in this context may partly be different from those sent to EFSA, which receives data
in principal from 1/1 to 31/12 (see Table H.2).
19 Regulation (EU) No 652/2014 of the European Parliament and of the Council of 15 May 2014 laying down provisions for the
management of expenditure relating to the food chain, animal health and animal welfare, and relating to plant health and
plant reproductive material, amending Council Directives 98/56/EC, 2000/29/EC and 2008/90/EC, Regulations (EC) No 178/
2002, (EC) No 882/2004 and (EC) No 396/2005 of the European Parliament and of the Council, Directive 2009/128/EC of the
European Parliament and of the Council and Regulation (EC) No 1107/2009 of the European Parliament and of the Council
and repealing Council Decisions 66/399/EEC, 76/894/EEC and 2009/470/EC.
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H.2.3. Creating a WIN-WIN situation for MSs, EFSA and the European
Commission with SIGMA and avoid double reporting of animal
population in the zoonoses domain
The different data streams regarding animal population in the zoonoses domain from MS to EFSA
and from MS to the European Commission are detailed above.
Data transmission
Currently, only few MSs (four) transmit their annual animal population in the zoonoses domain to
EFSA without manual manipulation and are extracted from national databases and transmitted to EFSA
using XML. The majority of the MSs, however, use an EFSA zoonoses Excel-based mapping tool where
data are manually inserted ad managed before sending to EFSA using an XML generating tool. The
shaping up of data in the EFSA mapping tool is very resource-intensive.
In addition, the MSs transmit their annual animal population data to the European Commission with
manual input in a PDF tool with an embedded XML structure.
Validation
It may be that the national reporters submitting the abovementioned data to EFSA and to the
European Commission are staff of different units or agencies (institutes) with different missions. This
may lead to some discrepancies across the different reports: despite the data are the same, a different
way of aggregating them may lead to apparent differences in counts and proportions.
For this reason MSs, EFSA and the European Commission carry out annually a thorough cross-
validation exercise to ensure that no discrepant statistics are published in the MSs’ national zoonoses
reports, nor in the EFSA scientiﬁc reports, nor in the reports published by the European Commission.
This exercise is extremely demanding and requires a lot of resources.
Leaning
The SIGMA Data Model is ﬂexible and can deal with many different types of data, from sample-
based to aggregated data. The SSD2, which deﬁnes the standards to describe the information related
Table H.2: Comparison between annual animal population data provided to EFSA and to the
European Commission
EFSA European Commission
Type of data Aggregated Aggregated
Scope Epidemiological analysis Claiming reimbursement (EU-approved and
veterinary programmes co-funded ONLY)
Need direct data transmission for ﬁnancial
accountability
Variables • types of ﬂocks or herds
• total number of animals
• total number of animals under the
programme
• total number of herds
• total number of herds under the
programme
• total number of herds tested, . . .
Information on the animal population
data model is on p. 42 and on the
disease status data model is on p. 45
and following of the annual zoonoses
monitoring data reporting on
zoonoses, food-borne outbreaks and
antimicrobial resistance (https://efsa.
onlinelibrary.wiley.com/doi/epdf/10.
2903/sp.efsa.2018.EN-1368)
Different data elements (only partial overlap) and
text forms
Data model seems comparable with EFSA but
more detailed analysis needed
Submission date 31 May 30 April
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to the individual sample, is part of the SIGMA Data Model, which ﬁts the requirements of the EFSA
Data Warehouse.
It is proposed that the MSs submit to EFSA using the relevant standards deﬁned by the SIGMA
Data Model all the data needed by EFSA and the European Commission as regards animal population
in the zoonoses domain. Once those data are submitted and stored in the Data Warehouse, all
concerned parties, with different levels of permission, will be able to access the relevant data to
generate different types of report. As an example, the MSs will be able to access their own data and
generate the national reports to be submitted to the European Commission or other type of reports for
internal use; the European Commission will be able to generate summaries and overviews based on
speciﬁc needs. This possibility will be implemented by means of web-based tools directly linked to the
data stored in the EFSA data warehouse.
This solution will save a lot of time and resources to the MS which will have to submit only once
the data of concern, which will be available to EFSA and the European Commission for more than
one purpose. In addition, the data will be standardised at EU level. The only action required to the
MSs is to align the data submitted to EFSA with the SIGMA Data Model standards. However, it
has to be noted that this work is carried out by the SIGMA Consortium which is ﬁnanced by
EFSA.
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